2024 Poster Presenters - CBD S&T Conference

Poster Listing

The poster presentation list is sorted by poster number then by poster session day (Tuesday or Wednesday). Please use the search function to locate presenter name, title, session, or poster presentation day. For additional sorting options click column headers.

Poster presenters will display and present during Poster Session I on Tuesday, December 3, or Poster Session II on Wednesday December 4. To view poster display instructions and schedule for hanging and removing posters visit the Poster Presenter Tab. Please note that final poster numbers will be confirmed closer to the conference.

View Poster Session Floorplans

Click to view poster map

Poster Presentation Day	Poster Number	Poster Presenter	Organization	Submission ID	Topic	Abstract Title	Room	Abstract
TUES	1	Peter Mikhael	MIT	59	AI/ML-assisted Redesign of Native Proteins	CLIPZyme: Reaction-Conditioned Virtual Screening of Enzymes	Hall A	View Abstract
WED	2	Doo Nam Kim	Pacific Northwest National Laboratory	25	AI/ML-assisted Redesign of Native Proteins	Computational Redesign of Monomeric Native Protein using Non-canonical Amino Acids	Hall A	View Abstract
TUES	3	Leonie Windeln	University of Southampton	444	AI/ML-assisted Redesign of Native Proteins	De novo Design of alpha-Conotoxin Binding Proteins	Hall A	View Abstract
TUES	4	Leonie Windeln	University of Southampton	443	Toxin Medical Countermeasures - Development of Novel, Broad-Spectrum Countermeasures for Toxin Exposure	How do Autoencoders Help Explore the Conformational Space of MD Simulations of Cyclic Peptides?	Hall A	View Abstract
TUES	5	Hannes Staerk	Massachusetts Institute of Technology	19	AI/ML-assisted Redesign of Native Proteins	Dirichlet Flow Matching with Applications to DNA Sequence Design	Hall A	View Abstract
WED	6	Jerome Alvarez	Naval Research Laboratory	29	AI/ML-assisted Redesign of Native Proteins	Nanobody Thermostability Prediction using Structural and Sequence Features	Hall A	View Abstract
TUES	7	Jorge Chavez	Air Force Research Laboratory	115	AI-powered Diagnostics	A closed-loop Wearable Platform for Synthetic Biology-powered Sensing and Delivery of Interventions	Hall A	View Abstract
WED	8	Lyman Monroe	Los Alamos National Laboratory	629	AI-powered Diagnostics	A new software for conotoxin identification and classification	Hall A	View Abstract
TUES	9	Armand Paauw	Netherlands Organization for Applied Scientific Research TNO, Department of CBRN Protection, The Netherlands	195	AI-powered Diagnostics	A proteomics-approach for Biological Threat Agents Detection and Identification	Hall A	View Abstract
WED	10	Jamie Inman	LBNL	418	AI-powered Diagnostics	A Reagent-free Portable Biosensor for Spectral Detection of biologically active molecules	Hall A	View Abstract
TUES	11	Patrick Chain	Los Alamos National Laboratory	728	AI-powered Diagnostics	A Sequence-based Pathogen-Agnostic Detection/Diagnostics Solution	Hall A	View Abstract
WED	12	Markus Antwerpen	Bundeswehr Institute of Microbiology	432	AI-powered Diagnostics	Development of an automated system for the analysis of large-scale patient care records	Hall A	View Abstract
TUES	13	Deborah Anderson	University of Missouri	552	AI-powered Diagnostics	Experimental model for development of machine learning to detect infection by a bioweapon	Hall A	View Abstract
WED	14	Kaitlyn Martinez	Los Alamos National Laboratory	596	AI-powered Diagnostics	Factors Influencing Accuracy, Interpretability, and Reproducibility in the use of Machine Learning in Biology	Hall A	View Abstract
TUES	15	Mark Maupin	PNNL	117	AI-powered Diagnostics	Finch: An AI-Powered Toolbox for the Prediction of Chemical Mixture’s Physiological Function and Hazard Profiles.	Hall A	View Abstract
WED	16	Daniel Jacobsen	Los Alamos National Laboratory	578	AI-powered Diagnostics	Identification of Bacterial Infection By Innate Immune Signature	Hall A	View Abstract
TUES	17	Apoorv Shanker	Los Alamos National Laboratory	533	AI-powered Diagnostics	Innate immune signatures of viral exposure in lung epithelial cells	Hall A	View Abstract
WED	18	Wenting Shao	University of Pittsburgh	610	AI-powered Diagnostics	Machine Learning Discrimination and Ultrasensitive Detection of Fentanyl Using Gold Nanoparticle-Decorated Carbon Nanotube-Based Field-Effect Transistor Sensors	Hall A	View Abstract
TUES	19	Anders Wallqvist	US Army	112	AI-powered Diagnostics	Mining public genomics data identifies potential kidney injury biomarkers	Hall A	View Abstract
TUES	20	Anders Wallqvist	US Army	110	Revolutionizing Biomedical Research: Integrating Cutting-edge AI/ML to Unleash Innovation in Drug Discovery and Therapeutics Development	Toxidrome screening: AI-based safety assessment of chemicals	Hall A	View Abstract
TUES	21	Anders Wallqvist	US Army	113	The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats	Can AI-based models serve as an alternative to experimental high-throughput screening?	Hall A	View Abstract
TUES	22	Anders Wallqvist	US Army	111	Revolutionizing Biomedical Research: Integrating Cutting-edge AI/ML to Unleash Innovation in Drug Discovery and Therapeutics Development	AI applications for assessing safety profiles of chemicals and drugs	Hall A	View Abstract
TUES	23	Krista Ternus	Signature Science, LLC	435	AI-powered Diagnostics	Predicting sequences of concern with machine learning	Hall A	View Abstract
WED	24	Lisa Bramer	Pacific Northwest National Laboratory	352	AI-powered Diagnostics	Profiling Healthy Human Breath using Artificial Intelligence	Hall A	View Abstract
TUES	25	Megan Guetzloff	Teledyne FLIR Defense	304	AI-powered Diagnostics	Rapid detection and classification of fentanyl analogs by 2D MS/MS coupled with a novel library-less machine learning algorithm	Hall A	View Abstract
WED	26	Jason Gans	Los Alamos National Laboratory	322	AI-powered Diagnostics	Recent progress towards rapid, automated design of nucleic acid-based pathogen diagnostic assays	Hall A	View Abstract
WED	27	Jason Gans	Los Alamos National Laboratory	326	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Enabling the rapid search of petabyte-scale DNA sequence databases with Bloom filters	Hall A	View Abstract
WED	28	Andrew Matas	Battelle Memorial Institute	332	AI-powered Diagnostics	Self-attention feature fusion: A platform for multimodal biomedical AI	Hall A	View Abstract
TUES	29	Jacob Beal	RTX BBN	540	AI-powered Diagnostics	Tactical Bioinformatics with Secure Bloom-Filter Analysis and Compression (SB-FAC)	Hall A	View Abstract
WED	30	Jane Preston	King's College London	196	CAMO (Comparing Animal Models to Organoids) - Testing Medical Countermeasures with Microphysiological Systems and Comparing to Traditional Animal Models and Clinical Trails	A syngenic porcine in vitro blood-brain barrier model predicts in vivo brain delivery of therapeutic antibodies.	Hall A	View Abstract
TUES	31	Aidan Tran	United States Military Academy	134	CAMO (Comparing Animal Models to Organoids) - Testing Medical Countermeasures with Microphysiological Systems and Comparing to Traditional Animal Models and Clinical Trails	Bacteriophage Therapy Rescues Caenorhabditis elegans from Pseudomonas aeruginosa Infection and Preserves the Gut Microbiome	Hall A	View Abstract
WED	32	Benjamin Wadsworth	United States Army Medical Research Institute of Chemical Defense	618	CAMO (Comparing Animal Models to Organoids) - Testing Medical Countermeasures with Microphysiological Systems and Comparing to Traditional Animal Models and Clinical Trails	Characterization of a humanized mouse model of organophosphate nerve agent poisoning and detection of countermeasures via MALDI-MSI.	Hall A	View Abstract
TUES	33	Christopher Cote	United States Army Medical Research Institute of Infectious Diseases (USAMRIID)	146	CAMO (Comparing Animal Models to Organoids) - Testing Medical Countermeasures with Microphysiological Systems and Comparing to Traditional Animal Models and Clinical Trails	Characterization of virulence of the Burkholderia pseudomallei ATS2021 strain isolated from aromatherapy spray unintentionally imported to the United States from India	Hall A	View Abstract
WED	34	Michael Barrera	George Mason University	353	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	The New World Alphavirus Inhibitor Bardoxolone Methyl Affects Host Kinases And Impacts Nonstructural Protein Production	Hall A	View Abstract
WED	35	Michael Barrera	George Mason University	347	CAMO (Comparing Animal Models to Organoids) - Testing Medical Countermeasures with Microphysiological Systems and Comparing to Traditional Animal Models and Clinical Trails	Comparison of therapeutic effectiveness of alphavirus nsP2 protease inhibitors in in vitro and in vivo models of infection by Venezuelan Equine Encephalitis Virus	Hall A	View Abstract
TUES	36	Sara Ruiz	USAMRIID	703	CAMO (Comparing Animal Models to Organoids) - Testing Medical Countermeasures with Microphysiological Systems and Comparing to Traditional Animal Models and Clinical Trails	Development of a Neurological Melioidosis Model	Hall A	View Abstract
TUES	37	Sara Ruiz	USAMRIID	701	CAMO (Comparing Animal Models to Organoids) - Testing Medical Countermeasures with Microphysiological Systems and Comparing to Traditional Animal Models and Clinical Trails	Impact of Co-infection on Disease Progression	Hall A	View Abstract
WED	38	J. Matthew Meinig	Bacteriology Division, U.S. Army Medical Research Institute of Infectious Diseases	376	CAMO (Comparing Animal Models to Organoids) - Testing Medical Countermeasures with Microphysiological Systems and Comparing to Traditional Animal Models and Clinical Trails	Establishing PK/PD drivers of therapeutic efficacy for bacterial threats: bridging in vitro and in vivo results using neutropenic mouse and hollow-fibre infection models	Hall A	View Abstract
TUES	39	Justin Sherlock	USAMRICD	341	CAMO (Comparing Animal Models to Organoids) - Testing Medical Countermeasures with Microphysiological Systems and Comparing to Traditional Animal Models and Clinical Trails	Evaluating airway responsiveness: leveraging a novel assay for assessing functional response in precision-cut lung slices (PCLS) from a humanized mouse model	Hall A	View Abstract
WED	40	Charles Shoemaker	USAMRIID	294	CAMO (Comparing Animal Models to Organoids) - Testing Medical Countermeasures with Microphysiological Systems and Comparing to Traditional Animal Models and Clinical Trails	Evaluation of host response to neurological infection with Burkholderia pseudomallei ATS2021 strain in C57BL/6 mice	Hall A	View Abstract
TUES	41	Olivia Bellek	USAMRICD	349	CAMO (Comparing Animal Models to Organoids) - Testing Medical Countermeasures with Microphysiological Systems and Comparing to Traditional Animal Models and Clinical Trails	Exploring the effects of in utero acute organophosphorus nerve agent (OPNA) exposure on mouse behavior	Hall A	View Abstract
WED	42	Seraiah Coe	MRICD	565	CAMO (Comparing Animal Models to Organoids) - Testing Medical Countermeasures with Microphysiological Systems and Comparing to Traditional Animal Models and Clinical Trails	Identifying epimutation inheritance following acute maternal organophosphorus nerve agent (OPNA) exposure	Hall A	View Abstract
TUES	43	John Dye	USAMRIID	23	CAMO (Comparing Animal Models to Organoids) - Testing Medical Countermeasures with Microphysiological Systems and Comparing to Traditional Animal Models and Clinical Trails	Marburg Virus Disease in Cynomolgus Monkeys for Development of Therapeutics	Hall A	View Abstract
WED	44	Michael Davies	USAMRIID	263	CAMO (Comparing Animal Models to Organoids) - Testing Medical Countermeasures with Microphysiological Systems and Comparing to Traditional Animal Models and Clinical Trails	Sex Differences in Protection Conferred by Heterologous Vaccines for Pneumonic Plague in an Aerosol Challenge Model	Hall A	View Abstract
TUES	45	Michelle Nelson	Dstl	96	CAMO (Comparing Animal Models to Organoids) - Testing Medical Countermeasures with Microphysiological Systems and Comparing to Traditional Animal Models and Clinical Trails	The Development of NHP ex vivo Tissue Models to Assess Host-pathogen Interactions and Medical Countermeasures	Hall A	View Abstract
WED	46	Colin Bishop	WFIRM	75	CAMO (Comparing Animal Models to Organoids) - Testing Medical Countermeasures with Microphysiological Systems and Comparing to Traditional Animal Models and Clinical Trails	Use of Animal OTEs to Determine the Appropriate Model Species for MCM Development	Hall A	View Abstract
TUES	47	SE HUN GU	Agency for Defense Development	298	CAMO (Comparing Animal Models to Organoids) - Testing Medical Countermeasures with Microphysiological Systems and Comparing to Traditional Animal Models and Clinical Trails	Viral infection and antiviral drug efficacy evaluation using organoids platform	Hall A	View Abstract
WED	48	Anuj (AJ) Singhal	CFD Research	684	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	7-Day Prophylactic Antiviral Patch with Host-Based MOA and Broad Spectrum Protection	Hall A	View Abstract
TUES	49	Lidimarie Trujillo Rodriguez	DTRA	309	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	A healthy human microbiome-informed method for enhancing in silico predictions of therapeutic phage safety	Hall A	View Abstract
WED	50	Travis Brown	Alexis Bio	11	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	A Host Disruption to Zika Virus Amplification via Genetically-engineered Porcine Colonies tested for mRNA-1893 tolerance	Hall A	View Abstract
TUES	51	Dominique Hall	Lawrence Livermore National Laboratory, Livermore	410	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	A Nanolipoprotein Particle Platform Vaccine Targeting Ebola Virus Elicits a Robust Immune Response In Vivo	Hall A	View Abstract
WED	52	Ariel Weinberger	Autonomous Therapeutics, Inc.	481	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	A New Class of RNA for Immediate, Broad-Spectrum & Precision Antiviral Protection	Hall A	View Abstract
TUES	53	John Prendergast	Recce Pharmaceuticals Ltd	404	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	A Novel Broad-Spectrum Rapid Response To MDR Bacterial Threats	Hall A	View Abstract
WED	54	Allyson Hirsch	Tulane University	262	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	A novel OMV adjuvant, T-vant, enhances the efficacy of the acellular pertussis vaccine	Hall A	View Abstract
TUES	55	Mark Poznansky	Vaccine and Immunotherapy Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA	318	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	A Self-Assembling Vaccine Platform for Flexible and Efficient Development of Prophylactic and Therapeutic Vaccines	Hall A	View Abstract
WED	56	Kumkum Ganguly	Los Alamos National Laboratory	580	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	A Tetra-cell Blood-Brain Barrier (BBB) Model System for High Throughput Screening of Medical Countermeasures (MCMs) for Rapid Response	Hall A	View Abstract
TUES	57	Apichai Tuanyok	University of Florida	215	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Advanced Phage-Based Strategies for Biodefense Against Burkholderia pseudomallei	Hall A	View Abstract
WED	58	Rick Kiessig	Kimer Med Limited	138	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Advancing rapid countermeasures against viral threats with the VTose® Antiviral Platform	Hall A	View Abstract
TUES	59	Steven Branda	Sandia National Laboratories	412	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Airway microbiome manipulation to counter respiratory infection	Hall A	View Abstract
WED	60	Thomas Laws	DSTL	68	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	An anti-inflammatory treatment strategy to ameliorate the pathogenic effects of Venezuelan Equine Encephalitis Virus infection.	Hall A	View Abstract
TUES	61	Jennifer Schwedler	Sandia National Labs	193	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	An Anti-VEEV BBB-penetrating bispecific provides comparable therapeutic protection in the context of VEEV-TrD infection in vivo	Hall A	View Abstract
WED	62	Rekha Panchal	USAMRIID	116	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Antiviral activity of Opaganib, a first-in-class sphingolipid modulator	Hall A	View Abstract
TUES	63	Matthew Coleman	Lawrence Livermore National Laboratory	715	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Apolipoprotein-nanodisc as a novel tool for solubilization and delivery of medical countermeasures.	Hall A	View Abstract
WED	64	Carl Gelhaus	Appili Therapeutics USA Inc	450	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	ATI-1701: Ongoing Development of a Live Attenuated Tularemia Vaccine Based on a SCHU S4 ΔclpB Mutant	Hall A	View Abstract
TUES	65	Andriy Buzun		415	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Bioreactor of emergent pathogen variants and ASF vaccine prophylaxis	Hall A	View Abstract
WED	66	Christina Gardner	U.S. Army Medical Research Institute of Infectious Diseases	598	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Bivalent VHH antibodies are protective against lethal Venezuelan equine encephalitis challenge in mice	Hall A	View Abstract
TUES	67	Katherine Besse	MIT Lincoln Laboratory	163	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Building innate warfighter resiliency against CB threats via the gut microbiome	Hall A	View Abstract
WED	68	Iris Jones	Sandia National Laboratories	436	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Characterization of a VSV-vectored vaccine platform for immunization against Burkholderia pseudomallei	Hall A	View Abstract
WED	69	Iris Jones	Sandia National Laboratories	434	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	A lipid nanoparticle mRNA vaccine expressing Ebola virus glycoprotein elicits strong immunological response and protection against challenge with a VSV-ZEBOVgp model of ZEBOV infection	Hall A	View Abstract
WED	70	Olivia Pimentel	Los Alamos National Laboratories	497	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Characterization of bacterial lipid nanodiscs as potential vaccine candidates	Hall A	View Abstract
TUES	71	Sharon Jan	Sandia National Laboratories	187	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Characterization of iron homeostasis during New World Arenavirus infection for therapeutic drug design	Hall A	View Abstract
WED	72	Morgen VanderGiessen	Virginia Tech	399	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Characterization of Neurological Sequelae Induced by Venezuelan Equine Encephalitis Virus	Hall A	View Abstract
TUES	73	Vladislav Sandler	Hemogenyx Pharmaceuticals	46	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Chimeric Bait Receptor (CBR) for Reprogramming of Myeloid Cells to Target and Eliminate Emerging Viral Infections	Hall A	View Abstract
WED	74	Gabrielle Rizzo	U.S. Army DEVCOM Chemical Biological Center	207	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Comparing Cost & Efficacy of Antibody Eequencing Using Microwave-assisted Acid Hydrolysis (MAAH) Digestion vs Enzymatic Digestion	Hall A	View Abstract
TUES	75	Amanda Casale	MIT Lincoln Laboratory	10	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Computational Model to Assess Medical Countermeasures for Dengue Fever	Hall A	View Abstract
WED	76	Chad Testa	Curza, Inc	459	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	CZ-02188 is a New Class of Antibacterial Agent, with a New Mechanism-of-action to Mitigate Multidrug-resistant Pathogens, Including Tier 1 Select Agents, with Efficacy in Mouse Models of Infection and Safety in Multiple Animal Species	Hall A	View Abstract
TUES	77	Courtney Cohen	USAMRIID	504	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Developing human monoclonal antibody-based therapies for Venezuelan equine encephalitis virus.	Hall A	View Abstract
WED	78	Nileena Velappan	Los Alamos National Laboratory	260	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Developing Nanofiber-Based Engineered Platforms for Enhanced Armed Forces Health and Biosecurity	Hall A	View Abstract
WED	79	Nileena Velappan	Los Alamos National Laboratory	449	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Nanobody Engineering for Novel Diagnostics	Hall A	View Abstract
WED	80	Kiran Sewsankar	Applied Research Associates, Inc.	619	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Development of a mathematical model of within-host dynamics of illness following biological agent exposure	Hall A	View Abstract
TUES	81	Jeff Hutchins	Inhalon Biopharma	559	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Development of an inhaled broadly neutralizing antibody treatment for seasonal and pandemic influenza A	Hall A	View Abstract
WED	82	Puttawat Suphaprueksapong	University of Florida	635	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Development of mRNA-Based Biologics Targeting PD-1 for Enhanced Melioidosis Management	Hall A	View Abstract
TUES	83	Chiho Yu	Agency for Defense Development	55	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Development of Rapid Therapeutics Platform Against Emerging Infectious Virus	Hall A	View Abstract
WED	84	Cherry Gupta	Battelle Memorial Institute	742	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	DNA origami nanostructures for effective targeted intracellular delivery of small molecule drugs.	Hall A	View Abstract
TUES	85	Caitlin Woodson	Virginia Tech	553	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	EGR1 influences neuropathology in mice following infection with Venezuelan equine encephalitis virus (VEEV) in a sex-dependent manner	Hall A	View Abstract
WED	86	Steven Hoang-Phou	Lawrence Livermore National Laboratory	695	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Encapsulation for supporting in situ cell-free generation and release of vaccine antigens	Hall A	View Abstract
TUES	87	Marie Kim	University of Chicago	354	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Enhanced innate recruitment and functionality after small molecule training as prophylactic for Listeria monocytogenes	Hall A	View Abstract
WED	88	Euni Sim	ABION Inc., Republic of Korea	433	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Enhancing DNA Vaccine Delivery Through Microneedle Patch Technology with Low-Voltage Electroporation	Hall A	View Abstract
TUES	89	Wei He	Lawrence Livermore National Laboratory	379	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Evaluating mRNA-Based Vaccines Against Burkholderia pseudomallei Infection	Hall A	View Abstract
WED	90	Matthew Seavey	Elusys Therapeutics, Inc.	22	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Evaluation of Immunogenicity and Efficacy of a Novel, Live Attenuated Anthrax Spore Vaccine, ‘LAV-BASTA-48’, for Postexposure Prophylaxis (PEP)	Hall A	View Abstract
TUES	91	Jason Ladner	Northern Arizona University	378	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	High resolution antibody profiles for evaluating vaccine platforms and identifying antigens	Hall A	View Abstract
WED	92	Hannah Riley Knight	University of Chicago	53	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	High Throughput Screen for Novel Small Molecule Inducers of Trained Immunity	Hall A	View Abstract
TUES	93	Allison Yorita	Lawrence Livermore National Laboratory	706	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Host-directed, bioelectronic immunomodulation for protection against emerging pathogens	Hall A	View Abstract
WED	94	Michael Norris	University of Hawaii	524	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Host-pathogen interactome analysis identifies key pathways for host targeted anti-toxin therapies	Hall A	View Abstract
WED	95	Michael Norris	PATH Group, University of Hawaiʻi at Mānoa	529	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Membrane engineering of outer membrane vesicles allows tunable interactions with the innate immune system	Hall A	View Abstract
WED	96	Michael Norris	PATH Group University of Hawaiʻi at Mānoa	268	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Vaccine Efficacy Against Antigenically Novel Anthrax Causing Pathogens	Hall A	View Abstract
TUES	97	Stephanie Monticelli	Virology Division, U.S. Army Medical Research Institute of Infectious Diseases/The Geneva Foundation	139	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Human derived monoclonal antibodies are protective against lethal Machupo virus challenge in guinea pigs	Hall A	View Abstract
WED	98	Lillian Chiang	Evrys Bio LLC	550	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Human sirtuin-2 protein (SIRT2) - a host-target providing broad-spectrum effectiveness through multiple mechanisms of viral restriction and immunity	Hall A	View Abstract
TUES	99	Joshua Breidenbach	Biochemistry and Biotechnology Group, Bioscience Division, Los Alamos National Laboratory	730	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Identification of countermeasures against viral replication by targeting viral entry-related host proteins	Hall A	View Abstract
WED	100	Christopher Sumner	Sandia National Laboratory	390	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Identification of host-targeting nanobodies disrupting new-world arenavirus receptor binding	Hall A	View Abstract
TUES	101	Carol Anderson	George Mason University	35	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Identification of Verteporfin and Protoporphyrin IX via medium throughput, in vitro screen where they act as robust, broad-spectrum inhibitors of emerging arthropod viruses.	Hall A	View Abstract
WED	102	Kristie Oxford	Pacific Northwest National Laboratory	589	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Identifying Host Responses to Predict Viral Pathogenesis and to Uncover Molecular Targets for Medical Countermeasures	Hall A	View Abstract
TUES	103	Michael Wannemuehler	Iowa State University	521	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Impact of gut microbial complexity on the host response to vaccination against A viral pathogen	Hall A	View Abstract
WED	104	Joel Bozue	USARMIID	51	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Implementation of a Post-Exposure Tularemia Treatment Model for Pneumonic Challenged Fischer Rats	Hall A	View Abstract
TUES	105	Spencer Stonier	Emergent BioSolutions	237	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Integrated, Rapid Antibody Discovery and Cell Line Development to Truncate Timelines for Manufacturing Teadiness	Hall A	View Abstract
TUES	107	Neeraj Kumar	Pacific Northwest National Lab	426	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	KESTREL: Knowledge Extraction for Strategic Threat Response using Evidence from the Literature	Hall A	View Abstract
WED	108	Jon Snedeker	Lactea Therapeutics	320	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Limiting biothreat exposure with a novel purified bioactive lactoferrin as a multifunctional countermeasure in battlefield wounds	Hall A	View Abstract
TUES	109	David Saunders	Uniformed Services University School of Medicine	121	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Live-Attenuated, Rearranged V4020 Vaccine for Venezuelan Equine Encephalitis: Preclinical Studies	Hall A	View Abstract
WED	110	Mahgol Behnia	UNIVERSITY of New Mexico	534	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	lncRNA Snhg15 positively regulates inflammatory response to Venezuelan equine encephalitis virus infection in primary mouse astrocytes	Hall A	View Abstract
TUES	111	Lindsay Odell	U.S. Department of Health and Human Services, Administration for Strategic Preparedness and Response, Biomedical Advanced Research and Development Authority	241	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Mitigating Severe Outcomes of Disease Caused by Emerging Threats	Hall A	View Abstract
WED	112	Ruy Ribeiro	Los Alamos National Laboratory	270	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Modeling the generation of vaccine-induced antibodies from multiple vaccine platforms	Hall A	View Abstract
TUES	113	Jason Thornton	University of Florida College of Veterinary Medicine Department of Infectious Diseases and Immunology	468	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Multivalent Outer Membrane Vesicle (OMV) Vaccine for Melioidosis and Glanders Disease	Hall A	View Abstract
WED	114	Riccardo D'Elia	DSTL	288	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Non-ionic surfactant vesicles (NISV) have host directed therapeutic potential and can be targeted to the brain	Hall A	View Abstract
TUES	115	Cesar de la Fuente	University of Pennsylvania	608	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Nonnegative matrix factorization approach to identify host-pathogen interactions and develop medical countermeasures to stem outbreaks	Hall A	View Abstract
TUES	116	James Collins	MIT	269	The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats	A Generative Deep Learning Approach to de novo Antibiotic Design	Hall A	View Abstract
TUES	117	Adam Taylor	Dstl	303	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Novel antibody based therapies have the potential to improve medical countermeasures for pathogens of defense concern.	Hall A	View Abstract
WED	118	Xiaofang Huang	Emergex USA	391	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Novel immunopeptidomic/machine learning integrated platform for next generation Chikungunya T cell priming vaccine development	Hall A	View Abstract
TUES	119	Haseebullah Baha	School of Systems Biology, College of Science, George Mason University	314	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	NRF2 signaling as a central, broad-spectrum host defense and response strategy against (re)emerging viral pathogens	Hall A	View Abstract
WED	120	Niloufar A. Boghdeh	School of Systems Biology, College of Science, George Mason University	421	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Omaveloxolone as a broad-spectrum intervention strategy against vector transmitted RNA viruses	Hall A	View Abstract
TUES	121	Ashley Brown	University of Florida	405	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Optimizing Combination Therapy with Antivirals and Host-Targeting Agents to Protect the Warfighter from Viral Threats	Hall A	View Abstract
WED	122	Bahman Asgharian	Applied Research Associates, inc.	344	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Optimizing Drug Delivery to the Respiratory Tract Using in silico Models	Hall A	View Abstract
TUES	123	Evan Lloyd	The Johns Hopkins University Applied Physics Laboratory	741	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Penems: Orally Available, Shelf Stable, Broad Spectrum Antibiotics	Hall A	View Abstract
WED	124	David Dantzker	Origin Life Sciences	24	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Plasma Nitric Oxide and the treatment of wounds	Hall A	View Abstract
TUES	125	Erik Settles	Northern Arizona University	532	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Potential vaccine correlates of protection: Evaluation of B cell and T cell receptors generated using different vaccine platforms.	Hall A	View Abstract
TUES	126	Erik Settles	Northern Arizona University	474	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Validation of OMV vaccine composition through immune reactivity and mass spectrometry to generate assays for manufacturing and clinical trials	Hall A	View Abstract
TUES	127	Gavin Morrow	IAVI	333	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Protective Vaccination of Nonhuman Primates against Aerosol Exposure to Marburg Virus using a Vesicular Stomatitis Virus-vectored Vaccine – Implications for Mucosal Vaccine Strategies and Unpredictable Filovirus Transmission	Hall A	View Abstract
WED	128	Carmen Molina-París	Los Alamos National Laboratory	478	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Quantification of human heterogeneity in CD8+ T cell responses: immune correlates of protection	Hall A	View Abstract
TUES	129	Jessica Kubicek-Sutherland	Los Alamos National Laboratory	94	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Rapid Assessment of Platform Technologies to Expedite Response (RAPTER)	Hall A	View Abstract
WED	130	Taehyung Kwon	Los Alamos National Laboratory	582	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Rapid Detection of Viral Infection With Host Epitranscriptional Signatures	Hall A	View Abstract
TUES	131	Bin Hu	Los Alamos National Laboratory	233	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	scRNA-seq Analysis of Melioidosis Patient Outcomes	Hall A	View Abstract
TUES	132	Bin Hu	Los Alamos National Laboratory	71	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Learning the Language of Proteins and Predicting the Impact of Mutations	Hall A	View Abstract
TUES	133	Madeline Bolding	Los Alamos National Laboratory	554	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Selecting antibodies against the Y. pestis lipid membrane in a nanodisc format	Hall A	View Abstract
WED	134	Ted Daley	Selva Therapeutics	606	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	SLV213: A novel orally-available Cathepsin inhibitor in development for potential treatment or prophylaxis against coronaviruses, filoviruses and paramyxoviruses	Hall A	View Abstract
TUES	135	Xiankun (Kevin) Zeng	USAMRIID	245	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Sudan Virus Persists in the Immune Privileged Organs of Nonhuman Primate Survivors	Hall A	View Abstract
WED	136	Monique van Hoek	George Mason University	636	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Sustained delivery of Vancomycin over time using QuickGel Click Hydrogel for the treatment of surgical site infections	Hall A	View Abstract
WED	137	Monique van Hoek	George Mason University	482	Revolutionizing Biomedical Research: Integrating Cutting-edge AI/ML to Unleash Innovation in Drug Discovery and Therapeutics Development	Coupling hemolysis predictor algorithms with real-world data for a defibrinated human blood hemolysis assay for the development of novel antimicrobial peptide therapeutics to target MDROs.	Hall A	View Abstract
WED	138	Monique van Hoek	George Mason University	488	Revolutionizing Biomedical Research: Integrating Cutting-edge AI/ML to Unleash Innovation in Drug Discovery and Therapeutics Development	Cell-penetrating peptide predictors to design delivery vehicles for morpholinos and peptide-nucleic acids to Pseudomonas aeruginosa.	Hall A	View Abstract
TUES	139	Beth Bachert	USMA	699	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Synergistic effects of novel phage cocktails with carbapenem antibiotics against multi-drug resistant Pseudomonas aeruginosa as a layered medical countermeasure	Hall A	View Abstract
WED	140	Nicholas Hum	Lawrence Livermore National Laboratory	711	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Targeting SPP1-positive Macrophages for Therapeutic Intervention in Pulmonary Infection	Hall A	View Abstract
TUES	141	Katherine Meiser	University of Missouri-Columbia	511	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Targeting Toll-like receptor 7 (TLR7) for intervention during pneumonic plague	Hall A	View Abstract
WED	142	Robert Lavieri	Quantum Leap Healthcare Collaborative	427	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	The ARDS Expansion of the I-SPY COVID Platform Clinical Trial	Hall A	View Abstract
TUES	143	Catalina Florez	USAMRIID	506	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Therapeutic efficacy of SNV-specific monoclonal antibodies in a novel STAT2 knockout Syrian Golden hamster disease model for Sin Nombre Virus infection	Hall A	View Abstract
WED	144	Harold Kim	Vasomune Therapeutics Inc.	594	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Threat Agnostic and Host-directed Therapeutic AV-001 to Treat Vascular Dysfunction: Randomized, Double-blind, Placebo-controlled Phase 1 Single and Multiple-dose First-in-Human Study in Healthy Subjects for the Treatment of Acute Respiratory Distress Syndrome	Hall A	View Abstract
TUES	145	Hiroyuki Nakashima	National Defense Medical College	87	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Training the innate immune system with low-dose endotoxin provides broad defense against bacteria-induced sepsis	Hall A	View Abstract
WED	146	Christian Xander	USAMRIID	84	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Treatment of bacterial biothreat agents with a novel purified bioactive bovine lactoferrin as a medical countermeasure	Hall A	View Abstract
TUES	147	Sanskruthi Sreepangi	George Mason University	464	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Ubiquitin E3 ligases as therapeutic targets towards achieving broad-spectrum inhibition of vector-transmitted, neurotropic viruses.	Hall A	View Abstract
WED	148	Kevin Mlynek	USAMRIID	82	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Understanding natural variation of LPS to promote attenuation in Francisella tularensis	Hall A	View Abstract
TUES	149	Sarah Harrison	The Johns Hopkins University, Applied Physics Laboratory	231	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Understanding the mechanisms of high-level ciprofloxacin resistance in Bacillus cereus sensu lato group of bacteria	Hall A	View Abstract
WED	150	Marisa Torres	Lawrence Livermore National Lab	751	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Vaccine Ranking Analysis Framework	Hall A	View Abstract
TUES	151	Sergei Biryukov	USAMRIID	100	Combatting Future Biological Threats – Host-Directed Interventions to Emerging Threats for Rapid Response	Yersinia Pestis NLP subunit vaccine platform: Protective efficacy and immunological profile	Hall A	View Abstract
WED	152	Patrick McNutt	Wake Forest University Health Sciences	614	Development of Immune Microphysiological Systems (Immune Systems on a Chip) for MCM Testing	Applying machine learning to human microphysiological systems to predict infection and virulence for new and emerging viruses	Hall A	View Abstract
TUES	153	Nina Hobi	AlveoliX AG, Swiss Organs-on-Chip Innovation, Switzerland	665	Development of Immune Microphysiological Systems (Immune Systems on a Chip) for MCM Testing	AXOrgan-on-chip Technology as a Model for Early Detection of Human Lung Toxicity	Hall A	View Abstract
WED	154	Jeff Borenstein	Draper Lab	676	Development of Immune Microphysiological Systems (Immune Systems on a Chip) for MCM Testing	Bioinspired microfluidic design of coagulation-free blood perfusion systems	Hall A	View Abstract
TUES	155	Dylan Fudge	US Army	52	Reaerosolization of Hazardous Materials: What Goes Down, Can Go Back Up Again	Biological Risk Evaluation and Threat Hazard Effects (BREATHE)	Hall A	View Abstract
TUES	156	Dylan Fudge	US Army	228	Threat Agent Defeat Modeling and Testing using WMD Simulants	Understanding Mixtures	Hall A	View Abstract
TUES	157	Dylan Fudge	US Army	225	Development of Immune Microphysiological Systems (Immune Systems on a Chip) for MCM Testing	Development of Immune Microphysiological Systems (Immune Systems on a Chip) for MCM Testing	Hall A	View Abstract
WED	158	Sarah Grady	Johns Hopkins University Applied Physics Laboratory	644	Development of Immune Microphysiological Systems (Immune Systems on a Chip) for MCM Testing	Immunity Twin: Utilizing mechanistic modeling and ML-informed image analysis to develop actionable medical interventions for challenges to human lung	Hall A	View Abstract
TUES	159	Rebecca Pompano	University of Virginia	714	Development of Immune Microphysiological Systems (Immune Systems on a Chip) for MCM Testing	Multi-organ models of the neuro-immune response to vaccination	Hall A	View Abstract
WED	160	Kambez Benam	University of Pittsburgh	600	Development of Immune Microphysiological Systems (Immune Systems on a Chip) for MCM Testing	Reconstitution of Human Hematopoietic Niche On-Chip for Real-Time Analysis of Leukocyte Mobilization and MCM Development	Hall A	View Abstract
TUES	161	Benjamin Miller	University of Rochester	687	Development of Immune Microphysiological Systems (Immune Systems on a Chip) for MCM Testing	Towards multi-organ tissue chips for modeling the human immune response to biothreat agents: the lung-brain interface	Hall A	View Abstract
WED	162	Mattheus Ueckermann	Creare LLC	69	eXtended Reality and Humanoid Robotics: NextGen Assets for Remote CB Response and Operation	3-D reconstruction, visualization, and modeling of buildings from multiple image sources	Hall A	View Abstract
TUES	163	Eva Lee	The Data and Analytics Innovation Institute	752	eXtended Reality and Humanoid Robotics: NextGen Assets for Remote CB Response and Operation	An Autonomous System for CBRN Critical Missions	Hall A	View Abstract
TUES	164	Eva Lee	The Data and Analytics Innovation Institute	750	Protection - Science and Technology Advances for Chemical and Biological Protection	RealOpt-Contingency – A Computational Platform for All Hazard and Disaster Planning, Training, and Response	Hall A	View Abstract
TUES	165	Robert Schwieterman	Teledyne FLIR	515	eXtended Reality and Humanoid Robotics: NextGen Assets for Remote CB Response and Operation	Digital Battlefield CB Threat Mapping and Augmented Reality Display	Hall A	View Abstract
WED	166	Lance McLean	Noblis ESI	675	eXtended Reality and Humanoid Robotics: NextGen Assets for Remote CB Response and Operation	Extended Reality for Chemical, Biological, Radiological, and Nuclear (CBRN) Training	Hall A	View Abstract
TUES	167	Tim Lawton	U.S. Army - DEVCOM Soldier Center	366	eXtended Reality and Humanoid Robotics: NextGen Assets for Remote CB Response and Operation	Integrated Multi-threat Headborne System (IMHS) – Heads-up Display for CBRN Information	Hall A	View Abstract
WED	168	Donovan Quimby	Aeris, LLC	523	eXtended Reality and Humanoid Robotics: NextGen Assets for Remote CB Response and Operation	Structurally Consistent Rapid Internal Building Estimation (SCRIBE)	Hall A	View Abstract
TUES	169	Ashley McGuirk	Applied Research Associates, Inc.	507	eXtended Reality and Humanoid Robotics: NextGen Assets for Remote CB Response and Operation	Using Virtual Reality to Explore Operational Utility, Virtual and Digital Twins for CBRN Situational Awareness	Hall A	View Abstract
WED	170	Samir Deshpande	U.S. Army DEVCOM Chemical Biological Center	463	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	: Near real-time analysis of long reads for detection of organisms using MinION sequencer	Hall A	View Abstract
TUES	171	Cassie Bryan	Draper Lab	671	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	A comprehensive bioinformatics pipeline for the identification of conserved binding sites enables broad-spectrum biological threat detection and MCM development	Hall A	View Abstract
WED	172	Aditi Naik	Draper Lab	498	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	A fieldable system for automated nucleic acid extraction	Hall A	View Abstract
TUES	173	Daniel Phillips	U.S. Army DEVCOM Chemical Biological Center	252	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	A field-reprogrammable toxin detection platform	Hall A	View Abstract
WED	174	Kjiersten Fagnan	Lawrence Berkeley National Laboratory	396	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	A framework for standardization of multi-omics data streams between the DOE Joint Genome Institute and National Microbiome Data Collaborative to support FAIR data generation	Hall A	View Abstract
TUES	175	Angela Zeigler	U.S. Army DEVCOM Chemical Biological Center	323	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	ABACUS- Autonomous BioAerosol Collection for Universal Sampling	Hall A	View Abstract
WED	176	Tilly Lawrence	Leidos	526	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Acceleration of clinical trials under pandemic conditions: lessons learned	Hall A	View Abstract
WED	177	Tilly Lawrence	Leidos	530	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	The synergistic observational research community of tomorrow (SORCoT): a deployable network to rapidly establish and administer decentralized trials	Hall A	View Abstract
WED	178	Alexander Verbitsky	Netrias	167	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	AI-Driven Harmonization	Hall A	View Abstract
TUES	179	Phillip Tomezsko	MIT Lincoln Laboratory	242	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	AI-enabled property prediction for characterization of novel proteins	Hall A	View Abstract
WED	180	Martyn Bull	Riskaware Ltd	486	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	An edge/cloud wearable technologies data infrastructure for detecting biological threats and physiological stress	Hall A	View Abstract
TUES	181	Miles Rogers	RTX BBN Technologies	499	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	An Integrated Nanophotonic Biosensor for Biological and Chemical Threat Detection	Hall A	View Abstract
TUES	183	Justin Taylor	Noblis	98	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Applying Machine Learning and Statistical Models to Low-cost Aerosol Densors for Anomaly Detection	Hall A	View Abstract
WED	184	Katherine Rhea	U.S. Army DEVCOM Chemical Biological Center	476	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Assessing the relationship between functionality and proteome of cell-free protein systems from Yersinia pestis	Hall A	View Abstract
TUES	185	Megan Howard	Battelle	306	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	BAT-NET: Bioinformatics Analysis Tool for Network Evaluation of Threats	Hall A	View Abstract
TUES	186	Megan Howard	Battelle	456	Quantum Technologies, Metamaterials, and the Future of CB Sensing	Quantum Multiplexed Molecular Nanoscale Sensors	Hall A	View Abstract
TUES	187	Taylor Moehling	Sandia National Laboratories	342	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Biophysics- and Biochemistry-Informed Machine Learning to Predict the Effect of Nucleotide Mutations on Molecular Detection Assays	Hall A	View Abstract
WED	188	Chuck Smallwood	Sandia National Laboratories	131	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Biosurveillance in Arctic Permafrost Soils Reveals Emergence of Pathogenic Bacteria and Viruses	Hall A	View Abstract
TUES	189	Lennart Justen	Media Lab, Massachusetts Institute of Technology; Draper Laboratory	201	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Biosurveillance of Emerging Viral Threats through Indoor Air Sampling: A Comprehensive Review	Hall A	View Abstract
WED	190	Brandon Fields	Fieldstone Bio, Inc.	383	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Biotechnology-Enabled Standoff Detection and Mapping of CB Agents	Hall A	View Abstract
TUES	191	Mark Munson	Naval Medical Research Command - Biological Defense Research Directorate	243	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Bridging study on transition of DBPAO assays to the Biomeme platform and additional assay development	Hall A	View Abstract
WED	192	Jessica Resnick	The Johns Hopkins University, Applied Physics Laboratory, Laurel, MD	336	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Cas9-assisted enrichment of metagenomic sequencing samples	Hall A	View Abstract
TUES	193	David Garcia	U.S. Army DEVCOM Chemical Biological Center	621	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Cell-free Detection of Small-Molecules Using Nanobody Conjugates	Hall A	View Abstract
WED	194	Dave Kimmel	Department of Homeland Security, Science and Technology	338	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Characterizing the Bioaerosol Composition Using Metagenomic Sequencing for Environmental Biodetection	Hall A	View Abstract
TUES	195	Ashish Chaudhary	Detect-ION	273	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Chip-Scale Mass Spectrometry for Point-of-Care Breath Diagnostics	Hall A	View Abstract
WED	196	Keersten Ricks	USAMRIID	97	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Companion Animal Mortality from Oral Exposure to Palytoxin with First Confirmation of Exposure in Clinical Samples	Hall A	View Abstract
TUES	197	Brad Abramson	Noblis	696	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Computer Vision for Multiplex Assay Detection	Hall A	View Abstract
WED	198	Michael Farrell	Georgia Tech Research Institute	126	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	CRISPR Cas13 for sensitive and specific detection of RNA viruses	Hall A	View Abstract
TUES	199	Daniel Ackerman	National Strategic Research Institute (NSRI)	627	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Cultivation and Propagation of Viable Viral Aerosols for Upstream Amplification and Infectivity Analysis	Hall A	View Abstract
WED	200	Robert Murdoch	BATTELLE MEMORIAL INSTITUTE	638	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Detection of genomic aberrations in viral genomes by measurement of phylogenetic distant attraction	Hall A	View Abstract
TUES	201	Julie Lucas	MRIGlobal	462	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Development and validation of ICECAP (Immobilized CRISPR Enriches Captured Target Pathogens) for on-demand pathogen detection	Hall A	View Abstract
WED	202	Paul Ippoliti	MIT Lincoln Laboratory	149	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Development of an LC-MS/MS-based integrated analysis pipeline for the detection of trace protein and small molecule toxins in complex matrices	Hall A	View Abstract
TUES	203	Ian Davis	US Army Medical Research Institute of Infectious Diseases	473	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Development of immunoassays for CCHFV proteins	Hall A	View Abstract
WED	204	Colin Price	MRIGlobal	603	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Development of the CasCADE CRISPR Detection guide RNA Design Pipeline	Hall A	View Abstract
TUES	205	Frederic Zenhausern	The University of Arizona College of Medicine-Phoenix	259	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Development of the VeriFAST system for multi-echelon diagnostics of multiplex agents	Hall A	View Abstract
WED	206	Brandon Pybus	USAMRIID	236	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Diagnostic Readiness Global Operational Network & Mobile Embedded Diagnostic Capabilities (DRAGON MEDIC), a paradigm for the rapid fielding of iterative prototype technology	Hall A	View Abstract
TUES	207	David Rozak	USAMRIID	407	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Evaluating engineered protease chain reactions as an adaptable, cross-platform technology for detecting new and emerging biological threat agents in laboratory and field environments	Hall A	View Abstract
WED	208	Melissa Adams	USAMRIID	86	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Far-forward real-time PCR assay manufacturing for rapid pathogen detection in austere or contested locations	Hall A	View Abstract
TUES	209	Kunal Poorey	Sandia National Labs	447	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	GenAI aided Synthetic Twin of a Population for Developing Accurate Low SWaP-C Multilayered Anomaly Detection	Hall A	View Abstract
WED	210	Jennifer Sekowski	U.S. Army DEVCOM Chemical Biological Center	173	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Genomic Non-specific Operational Matchmaking Enabled Systems (G-NOMES): Innovative acquisition for low-SWAP, modular, automated biological sample preparation for field forward agnostic sequencing for emerging biological threats	Hall A	View Abstract
TUES	211	Maria Nevarez Martinez	Los Alamos National Laboratory	265	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Giant quantum dots (gQDs) as fluorescent probes for improved antibody-antigen interaction studies through 3D quantum-enhanced single particle tracking	Hall A	View Abstract
WED	212	Damian Honeyman	Kirby Institute	143	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Global Event-based Surveillance of Chemical Incidents from Open-source Intelligence	Hall A	View Abstract
TUES	213	Matthew Lux	U.S. Army DEVCOM Chemical Biological Center	508	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Hall A	View Abstract
WED	214	Karlyn Harrod	Oak Ridge National Laboratory, National Security Sciences Division	566	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Integrating Biosurveillance and Climate Data for Vectorborne Disease Risk Mapping and Prediction	Hall A	View Abstract
TUES	215	Srivatsan Raman	University of Wisconsin-Madison	199	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Leveraging allosteric transcription factors to detect small molecule threats	Hall A	View Abstract
WED	216	Kurt Gust	US Army Engineer Research and Development Center	393	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Leveraging Cryptobiosis Mechanisms to Develop Ruggedized Cells for Biological Sensing in Austere Environments	Hall A	View Abstract
TUES	217	Joshua Whiting	Sandia National Laboratories	719	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Leveraging FAID for biological sample analysis	Hall A	View Abstract
WED	218	Charles DeSanti	Battelle	365	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Location-specific Volatile Organic Compounds detected in Bacillus anthracis Delta Sterne Spore preparations.	Hall A	View Abstract
TUES	219	Casey Bernhards	U.S. Army DEVCOM Chemical Biological Center	584	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Low burden sensors for in-field detection of water contaminants based on synthetic biology and cell-free expression systems	Hall A	View Abstract
WED	220	Rahul Rao	Air Force Research Laboratory	613	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Machine learning-enabled development of SERS sensors for the detection of trace analytes	Hall A	View Abstract
TUES	221	Josh Dettman	MIT Lincoln Laboratory	47	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Melding Experimental and AI Approaches for Threat Sensing and Characterization	Hall A	View Abstract
WED	222	Bharat Poudel	Oregon State University	722	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Metadynamics Free Energy Analysis of High Temperature Degradation of Fentanyl	Hall A	View Abstract
TUES	223	Rebecca Lilly	The Johns Hopkins University Applied Physics Laboratory	250	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Miniaturized Airborne Threat Assessment & Detection sensOR (MATADOR)	Hall A	View Abstract
WED	224	Kevin Yehl	Miami University	561	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Multiplexing DNA sensors and using pattern recognition to detect a range of chemical and biological threats using a single test platform	Hall A	View Abstract
TUES	225	Kamil Khanipov	University of Texas Medical Branch	307	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Nationwide Bioaerosol Metagenomic Repository for Environmental Biodetection	Hall A	View Abstract
WED	226	Cory Bernhards	U.S. Army DEVCOM Chemical Biological Center	670	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	NATO Technical Activity: Sequencing for Environmental Aerosol Background Monitoring	Hall A	View Abstract
WED	227	Cory Bernhards	U.S. Army DEVCOM Chemical Biological Center	316	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Development of untargeted nanopore-based systems for agnostic biological threat identification in the field	Hall A	View Abstract
WED	228	Andrea Luquette	Naval Medical Research Command	152	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Novel TaqMan Assay for the Detection of Mayaro Virus Circulation in South America	Hall A	View Abstract
TUES	229	Jenna Gadberry	STC supporting U.S. Army DEVCOM Chemical Biological Center	350	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Olfactory Science: Asymmetric Threat Detection	Hall A	View Abstract
WED	230	Christopher Stefan	USAMRIID	591	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Pathogen Identification using Isothermal Amplification and Next-Generation Sequencing Technologies	Hall A	View Abstract
TUES	231	Paula Millirons	GeneCapture, Inc.	261	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Pathogen X detection using one-hour screen in austere environments	Hall A	View Abstract
WED	232	Jennifer Morales	DEVCOM Army Research Lab	388	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Photonic Integrated Circuits and Protein Catalyzed Capture Agents as a Multiplexed, Heat and Shelf Stable Biosensor for Biological Targets	Hall A	View Abstract
WED	233	Jennifer Morales	DEVCOM Army Research Lab	389	Quantum Technologies, Metamaterials, and the Future of CB Sensing	Ultra-low SWaP-C, Photonic Integrated Circuit sensors for the multiplexed detection of organo-phosphate simulants	Hall A	View Abstract
WED	234	Christian Schafmeister	ThirdLaw Molecular LLC	28	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Progress in Developing SYMBAs - SYnthetic Molecular Binding Agents to Replace Monoclonal Antibodies in Diagnostic Tests	Hall A	View Abstract
TUES	235	T.C. Folkedal	Noblis	643	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	PSIDO: Predictive Surveillance of Infectious Disease Outbreaks	Hall A	View Abstract
TUES	237	Darci Smith	Naval Medical Research Command	448	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Rapid Detection of Blood Based Biomarkers for Emerging Biological Threats that Cause Brain Injury	Hall A	View Abstract
WED	238	Neal Satterly	Chemring Sensors and Electronic Systems	368	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Rapid, affordable, and scalable response to emerging biological threats	Hall A	View Abstract
TUES	239	Joseph Lacirignola	MIT Lincoln Laboratory	639	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Rapid, Autonomous, High-Confidence Bioaerosol Sensing	Hall A	View Abstract
WED	240	Christopher Harrilal	Earth and Biological Sciences Directorate, Pacific Northwest National Laboratory	713	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Reference-free chemical threat characterization	Hall A	View Abstract
TUES	241	Sean Kinahan	DHS S&T	491	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Science Watch: A Systematic Approach to the Identification and Evaluation of Rapidly Evolving 21st Century Chemical and Biological Threats	Hall A	View Abstract
TUES	242	Sean Kinahan	DHS S&T	495	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	The Five Research and Development (5RD) Council's Global Biodefense Network (GBDN) Approach to Synchronizing and Sharing Research in the Fate of Emergent Biological Agents in the Environment (FAtE)	Hall A	View Abstract
TUES	243	Sean Kinahan	DHS S&T	693	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	DHS S&T Master Question Lists (MQLs) provide decision makers and stakeholders reference information and needed information on traditional and emerging biological agents	Hall A	View Abstract
WED	244	Kemper Talley	RTX BBN Technologies	279	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Secure Bloom-Filter Analysis of Sequenced Threats in Real-Time (SB-FASTR) for Wastewater	Hall A	View Abstract
TUES	245	Sterling Sawaya	GeneInfoSec Inc.	26	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Sharing Accurate and Secure Pathogen Genome Data	Hall A	View Abstract
WED	246	Jennifer Stone	MRIGlobal	466	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Simplification and Automation of a Biological Sequencing Workflow for Threat-Agnostic Detection in Field Settings	Hall A	View Abstract
TUES	247	Jennifer Lee	Defense Threat Reduction Agency	223	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Solution blow spinning of cell-free functionalized polymer fibers for the detection of emerging biological threats	Hall A	View Abstract
WED	248	Anastasiia Kim	LANL	624	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Statistical relationships across epigenomes using large-scale hierarchical clustering	Hall A	View Abstract
TUES	249	Adina Doyle	U.S. Army DEVCOM Chemical Biological Center	424	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Streamlining nanopore sequencing protocols for untargeted RNA virus identification in the field	Hall A	View Abstract
WED	250	Oliver Nakano-Baker	University of Washington	707	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	The bio-inspired nose-on-a-chip for mobile sensing and breath-based diagnostics	Hall A	View Abstract
TUES	251	Niranjan Haridas Menon	New Jersey Institute of Technology	740	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	The development of a modular platform technology for the early detection of zoonotic diseases	Hall A	View Abstract
WED	252	Haydon Hill	University of Nevada, Reno School of Medicine	743	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	The development of a portfolio of antibodies to facilitate the point-of-need detection of bacterial, viral, and toxin biothreats	Hall A	View Abstract
TUES	253	Frederik Schulz	Lawrence Berkeley National Laboratory	244	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Towards sequencing for agnostic discriminative detection of biological threats with outbreak potential	Hall A	View Abstract
WED	254	Susan Kozawa	U.S. Army DEVCOM Chemical Biological Center	592	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Utilization of Bioprinting to fabricate tunable tissues: a polymeric perspective	Hall A	View Abstract
WED	255	Susan Kozawa	U.S. Army DEVCOM Chemical Biological Center	593	Protection - Science and Technology Advances for Chemical and Biological Protection	Understanding the effects of processing on fiber/Mof composites	Hall A	View Abstract
WED	256	Christopher Puglisi	Netrias	380	Innovating Cross-domain Solutions to Detect Emerging Biological Threats	Viral threat detection from proteomics data with machine learning	Hall A	View Abstract
TUES	257	Howard Walls	RTI International	34	Innovative Approaches to Elucidate Optimal Deployment of CB Sensing Assets	A Modular System Architecture for Securely acquiring, Transmitting, and Processing Data from Wireless Chem-bio Sensors	Hall A	View Abstract
WED	258	Brooke Ahern	U.S. Army DEVCOM Chemical Biological Center	205	Innovative Approaches to Elucidate Optimal Deployment of CB Sensing Assets	Bioindustrial Manufacturing Assessment for Tactical Operations: A Paper Study	Hall A	View Abstract
TUES	259	Michele Maughan	DEVCOM CBC	251	Innovative Approaches to Elucidate Optimal Deployment of CB Sensing Assets	IronDog: Introducing the future four-legged warfighter	Hall A	View Abstract
WED	260	Joshua Uzarski	US Army DEVCOM Soldier Center	646	Innovative Approaches to Elucidate Optimal Deployment of CB Sensing Assets	Novel Generative AI for sensors: augmenting downstream deployed sensors for improved agent detection and identification	Hall A	View Abstract
TUES	261	Joseph Russell	MRIGlobal	664	Innovative Approaches to Elucidate Optimal Deployment of CB Sensing Assets	Seeing the trees for the forest -- Identifying trap-door genomics records ahead of your bioinformatics workflow	Hall A	View Abstract
WED	262	Jordan Lefebvre	Aeris, LLC	545	Innovative Approaches to Elucidate Optimal Deployment of CB Sensing Assets	Tactical Awareness Kit Tactical Sensor Placement	Hall A	View Abstract
TUES	263	Carolanne ONeil	Domenix	103	Innovative Approaches to Elucidate Optimal Deployment of CB Sensing Assets	Unveiling Strategic Insights: Leveraging Domenix's Universal Protocol Adapter for Enhanced Deployment of Sensor Assets and AI/ML Integration	Hall A	View Abstract
WED	264	Charles Carrington	IndoorGEO, LLC	311	Innovative Approaches to Elucidate Optimal Deployment of CB Sensing Assets	Using AI/ML to leverage up-to-date building plans, which exist for the vast majority of buildings worldwide and are currently wholly unusable, and to search within these building plans or across entire government database(s) containing these plans as raw permitting records for indicia of chemical and biological weapons manufacture, storage and transportation, in real time, at scale and with global reach, including any type of building data typically found in a set of building plans such as indicia of biological, chemical and other activities, basements, hidden rooms, server/control rooms, video/security systems (ethernet and optical fiber), WiFi, electrical closets, service panels, mechanical rooms and ventilation, structural elements and wall composition (concrete block, steel-reinforced concrete, wood-frame, etc..)	Hall A	View Abstract
TUES	265	Cecilia Phung	DEVCOM CBC	348	Localizing Chemical and Biological Threat Detection	Assessment of Surface and Ground hAzards by Real-time Detection (ASGARD): Deposition Methodology Development and Characterization	Hall A	View Abstract
WED	266	Eric Peters	MRIGlobal	400	Localizing Chemical and Biological Threat Detection	Ballistic GC (BGC) for CWA Vapor Analysis	Hall A	View Abstract
TUES	267	Kakali Bandyopadhyay	Airanaculus.com	726	Localizing Chemical and Biological Threat Detection	Biological and Chemical Threat Prediction and Reasoning System (BiCEPS) to aid detection of Biological and Chemical Threat	Hall A	View Abstract
WED	268	Nicholas Fitzgerald	Defence Science and Technology Group - Department of Defence Australia	419	Localizing Chemical and Biological Threat Detection	CASES - A low-SWaP low-cost "wearable" for early warning of airborne pathogen exposure.	Hall A	View Abstract
TUES	269	Steven Pullins	Leidos	549	Localizing Chemical and Biological Threat Detection	Chemical Aerosol Remote Sensing: the intelligent Chemical Aerosol Transmission Spectrometer (iCATS)	Hall A	View Abstract
WED	270	Meredith Melendez	Leidos	551	Localizing Chemical and Biological Threat Detection	Chemical Aerosol Remote Sensing: the intelligent Chemical Aerosol Transmission Spectrometer (iCATS) Aerosol Test Chamber	Hall A	View Abstract
TUES	271	Neha Mishra	University of Colorado Anschutz Medical Campus	247	Localizing Chemical and Biological Threat Detection	Clinical biomarkers of acute toxicity induced by mustard vesicant exposure in the ocular tissue	Hall A	View Abstract
TUES	273	Sara Paalhar	MRIGlobal	402	Localizing Chemical and Biological Threat Detection	Colorimetric Sensors for Rapid Reliable Threat Identification	Hall A	View Abstract
TUES	274	Sara Paalhar	MRIGlobal	403	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	Decontamination Efficacy Testing for CWA Mitigation	Hall A	View Abstract
TUES	275	Cody Corbin	Sandia National Laboratories	17	Localizing Chemical and Biological Threat Detection	Colorimetric/Electrical Sensing of Chemical Warfare Agent Surrogates with Polydiacetylenes	Hall A	View Abstract
WED	276	Christopher Breshike	US Naval Research Laboratory	58	Localizing Chemical and Biological Threat Detection	Detection of Dimethyl Methylphosphonate (DMMP) with an Interband Cascade Laser Sensor	Hall A	View Abstract
TUES	277	Anthony Politza	The Pennsylvania State University	616	Localizing Chemical and Biological Threat Detection	Development and Validation of a Portable Device for Lab-Free Universal Nucleic Acid Extraction	Hall A	View Abstract
WED	278	Migun Shakya	Los Alamos National Laboratory	579	Localizing Chemical and Biological Threat Detection	Environmental biomonitoring for detecting nefarious biological agents	Hall A	View Abstract
TUES	279	Jill Lundell	MIT Lincoln Laboratory	513	Localizing Chemical and Biological Threat Detection	Exploratory Analysis of Multi-sensor Wearables Data on Chemical Exposure	Hall A	View Abstract
WED	280	Yongle Pan	DEVCOM Army Research Laboratory	472	Localizing Chemical and Biological Threat Detection	Fast Bioaerosol Warning Sensor Using Single Particle Differential Circular Polarization Scattering (CIDS)	Hall A	View Abstract
TUES	281	Evan Durnal	MRIGlobal	395	Localizing Chemical and Biological Threat Detection	High-Purity Vapor Generation of Semi-Volatile Chemical Agents for Wearable Sensor Validation	Hall A	View Abstract
TUES	282	Evan Durnal	MRIGlobal	392	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	Decontamination Efficacy Validations for Clandestine Site Remediation Motivating development of a standard practice	Hall A	View Abstract
TUES	283	William Brubaker	SRI International	729	Localizing Chemical and Biological Threat Detection	Host-response biomarkers in interstitial fluid: individual baselines, marker kinetics, and implications for wearable devices and continuous monitoring.	Hall A	View Abstract
WED	284	Frederick Marcotte	Telops	649	Localizing Chemical and Biological Threat Detection	Improved Chemical Gas Detection and Identification for Thermal Infrared Hyperspectral Remote Sensing	Hall A	View Abstract
TUES	285	Daniel Reyes Duram	Institute for Human and Machine Cognition	258	Localizing Chemical and Biological Threat Detection	Improving CBRNE Situational Awareness using Wearable KENNEL Threat Detection Boxes	Hall A	View Abstract
WED	286	David Schiering	Redwave Technology	203	Localizing Chemical and Biological Threat Detection	In-field Vapor Threat Identification Using FT-IR Spectroscopy in Mounted and Dismounted Modalities	Hall A	View Abstract
TUES	287	Shawna Gallegos	U.S. Army DEVCOM Chemical Biological Center, Oak Ridge Institute for Science and Education, US Department of Energy (ORISE; Oak Ridge)	232	Localizing Chemical and Biological Threat Detection	Leveraging analytical chemistry and advanced flow visualization for the identification of trace levels of threat material	Hall A	View Abstract
WED	288	Meghan Hegarty-Craver	RTI International	33	Localizing Chemical and Biological Threat Detection	Lightweight Wearables-based Algorithms for Detecting Exposure to Chemical, Biological, and Environmental Threats	Hall A	View Abstract
WED	289	Meghan Hegarty-Craver	RTI International	32	Localizing Chemical and Biological Threat Detection	Using Wearables-based Health Data for AI-powered Diagnostics	Hall A	View Abstract
TUES	291	Ambalavanan Jayaraman	TDA Research	694	Localizing Chemical and Biological Threat Detection	Person wearable sensors for chemical agent detection including TICs	Hall A	View Abstract
WED	292	Donald Huston	National Strategic Research Institute (NSRI)	678	Localizing Chemical and Biological Threat Detection	Risk exposure and mitigation of potentially airborne infectious diseases on the USNS Mercy, a Navy hospital ship	Hall A	View Abstract
TUES	293	Robert Waterbury	Alakai Defense Systems	567	Localizing Chemical and Biological Threat Detection	Small Standoff Trace Detection Sensor for Handheld and UGV/UAV Applications	Hall A	View Abstract
WED	294	Matthew Aernecke	908 Devices	475	Localizing Chemical and Biological Threat Detection	The Risk Disk – a platform for forward deployed chemical collection and analysis	Hall A	View Abstract
TUES	295	Miles Egan	Leidos	555	Localizing Chemical and Biological Threat Detection	Trace Aerosol Signature Detection and Classification Using Standoff Quantum Cascade Laser Absorption Spectroscopy: Preliminary Forward Modeling Results from the IARPA PICARD Program	Hall A	View Abstract
WED	296	Brian Thomson	N5 Sensors Inc.	518	Localizing Chemical and Biological Threat Detection	Wearable chemical sensors for improved situational awareness	Hall A	View Abstract
TUES	297	Philip Miller	Sandia National Laboratories	735	Localizing Chemical and Biological Threat Detection	Wearable Chemical Threat and Volatile Organic Compound Detector	Hall A	View Abstract
WED	298	Jefferey Borenstein	Draper Lab	465	Medical Prophylaxis to Mitigate Chemical Threats	A high-throughput human primary cell-based blood-brain barrier model for evaluation of treatments and prophylaxis for nerve agents	Hall A	View Abstract
TUES	299	Joe Harford	SynerGene Therapeutics, inc.	37	Medical Prophylaxis to Mitigate Chemical Threats	An oxime nanoformulation designed to cross the blood-brain barrier results in more brain acetylcholinesterase reactivation, less brain damage, and better survival rates in paraoxon-exposed mice	Hall A	View Abstract
WED	300	Dan Stevens	Dstl	662	Medical Prophylaxis to Mitigate Chemical Threats	Assessment of naltrexone and nalmefene as prophylactic treatment against carfentanil exposure in a non-human primate model	Hall A	View Abstract
TUES	301	Lukas Gorecki	University Hospital Hradec Kralove, Biomedical Research Center	130	Medical Prophylaxis to Mitigate Chemical Threats	Bifunctional Compounds Serving As Versatile Causal Antidotes Against Nerve Agents	Hall A	View Abstract
WED	302	Joseph Kotzker	Kotzker Phfarma, LLC	147	Medical Prophylaxis to Mitigate Chemical Threats	Cannabinoids for Prophylaxis, Enhanced Neuroprotection and Therapy Against Organophosphate (OP) Chemical War Nerve Agents	Hall A	View Abstract
TUES	303	Terry Thiem	National Strategic Research Institute	590	Medical Prophylaxis to Mitigate Chemical Threats	Continuous Subcutaneous Infusion of SEVALENT Formulations Enabling Prophylactic Use of CBRN Medical Countermeasures	Hall A	View Abstract
WED	304	Marco Pravetoni	University of Washington	192	Medical Prophylaxis to Mitigate Chemical Threats	Development of vaccines and antibody-based countermeasures to prevent and treat exposure to ultra potent synthetic opioids	Hall A	View Abstract
WED	305	Marco Pravetoni	University of Washington	602	Revolutionizing Biomedical Research: Integrating Cutting-edge AI/ML to Unleash Innovation in Drug Discovery and Therapeutics Development	Rational design of antibody-based countermeasures against fentanyl, carfentanil, and ultrapotent synthetic opioids	Hall A	View Abstract
WED	306	James Talton	Alchem Laboratories Corp.	27	Medical Prophylaxis to Mitigate Chemical Threats	Discovery and Development of Small Molecule AChE Reactivators	Hall A	View Abstract
TUES	307	Sofiya Micheva-Viteva	Los Alamos National Laboratory	181	Medical Prophylaxis to Mitigate Chemical Threats	Discovery of Therapeutic Countermeasures Against Injuries Induced by Nerve Agents	Hall A	View Abstract
WED	308	Mital Patel	Walter Reed Army Institute of Research	211	Medical Prophylaxis to Mitigate Chemical Threats	Dose-dependent Effects of Fentanyl in Mouse Cortex: An Integrative mRNA-miRNA Profiling Approach	Hall A	View Abstract
TUES	309	John McManus	Partner Therapeutics, Inc.	510	Medical Prophylaxis to Mitigate Chemical Threats	Expanding the use of an FDA-approved host-directed therapy for known and unknown threats: Treating pancytopenia and immune dysregulation due to acute radiation or sulfur mustard (HD) exposure with Leukine® [sargramostim/recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF)]	Hall A	View Abstract
WED	310	Bob Moyer	Battelle	300	Medical Prophylaxis to Mitigate Chemical Threats	In Vitro Assessment of the Ferret Model for Nerve Agent Medical Countermeasure Evaluation	Hall A	View Abstract
TUES	311	Kamil Kuca	University of Hradec Králové	704	Medical Prophylaxis to Mitigate Chemical Threats	Optimization of Asoxime Formulations for Enhanced Solubility and Reactivation Efficacy: Implications for Nerve Agent Poisoning Treatment and Design of Novel Autoinjector	Hall A	View Abstract
WED	312	Genesis Lopez-Cazares	Sandia National Laboratories	573	Medical Prophylaxis to Mitigate Chemical Threats	Optimization of Lipid-Coated Mesoporous Silica Nanoparticles for BBB targeted delivery of 2-PAM to the CNS	Hall A	View Abstract
TUES	313	Narender Singh	CFD Research	132	Medical Prophylaxis to Mitigate Chemical Threats	Organophosphate nerve agent-induced transcriptome changes in human cells to identify drug targets	Hall A	View Abstract
WED	314	Manish Moghe	Georgetown University Medical Center	38	Medical Prophylaxis to Mitigate Chemical Threats	Preventing neuronal losses after organophosphate exposures by curbing neuroinflammation via a novel nanoformulation of pralidoxime designed to cross the blood-brain barrier	Hall A	View Abstract
TUES	315	Kevin Miller	Ohio State University	317	Medical Prophylaxis to Mitigate Chemical Threats	Protection Against Organophosphorus Threats: Quinone Methide Precursors for the Broad-Scope Treatment of OP-Inhibited AChE and BChE, and OP-Aged AChE	Hall A	View Abstract
WED	316	Christopher Hadad	Ohio State University	312	Medical Prophylaxis to Mitigate Chemical Threats	Quinone Methide Precursors for Remediating Organophosphorus Intoxication: Novel Reactivators of OP-inhibited and Resurrectors of OP-aged Cholinesterases	Hall A	View Abstract
TUES	317	Francine Katz	The City College of New York	454	Medical Prophylaxis to Mitigate Chemical Threats	Regulation of actin depolymerization resulting from lung injury	Hall A	View Abstract
WED	318	Jonathan Boyd	Virginia Commonwealth University	101	Medical Prophylaxis to Mitigate Chemical Threats	Spatiotemporal Inflammation Associated with Agent Exposure	Hall A	View Abstract
TUES	319	Jennie Wang	SRI	160	Medical Prophylaxis to Mitigate Chemical Threats	Stability-indicating HPLC Method Development and Impurity Characterization for a Broad-spectrum Reactivator Against a Highly Toxic Organophosphorus Compound, HLö 7 dimethanesulfonate (HLö 7 DMS)	Hall A	View Abstract
WED	320	Emilia Solomon	Los Alamos National Laboratory	129	Medical Prophylaxis to Mitigate Chemical Threats	Tissue Protective and Regenerative Therapies Counteracting Nerve Agent Damage	Hall A	View Abstract
TUES	321	Brian Jun	Los Alamos National Laboratory	601	Microphysiological Systems as Tools for Non-Invasive Diagnostics	3D-Printed Perfusion Bioreactor for Brain Vascular Permeability Assessment	Hall A	View Abstract
WED	322	Taalin Hoj	United States Army Research Institute of Infectious Disease	337	Microphysiological Systems as Tools for Non-Invasive Diagnostics	Comparing Immune Responses to B. pseudomallei Infection in a Lymphoid Follicle MPS and a C57BL/6 Mouse Model	Hall A	View Abstract
TUES	323	S. Emma Sarles	U.S. Army DEVCOM Chemical Biological Center	176	Microphysiological Systems as Tools for Non-Invasive Diagnostics	Exploration of in vitro methods for investigating mechanism of action of Sulfur Mustard (HD)	Hall A	View Abstract
WED	324	Priscilla Lee	U.S. Army DEVCOM Chemical Biological Center	174	Microphysiological Systems as Tools for Non-Invasive Diagnostics	Harnessing bioprinting technology to develop more customizable and physiologically relevant skin models against vesicant exposure	Hall A	View Abstract
TUES	325	Joshua Dye	Darwin Biosciences	581	Microphysiological Systems as Tools for Non-Invasive Diagnostics	Improving point-of-need diagnostic readouts across amplification chemistries	Hall A	View Abstract
WED	326	Harshini Mukundan	Lawrence Berkeley National Laboratory	257	Microphysiological Systems as Tools for Non-Invasive Diagnostics	Innate Immunity as a Model System for Development of Agnostic Diagnostics for Known and Emerging Threats	Hall A	View Abstract
TUES	327	Krysten Jones	Air Force Research Laboratory	469	Microphysiological Systems as Tools for Non-Invasive Diagnostics	Integrated Human Neurovascular Unit-on-a-Chip for Machine Learning-based Prediction of Neurotoxin Exposure	Hall A	View Abstract
WED	328	Gillian McMahon	University of California, San Diego	585	Microphysiological Systems as Tools for Non-Invasive Diagnostics	Leveraging human organoid models and advanced microscopy to probe 4D mitochondrial dynamics with applications in drug development and toxicology	Hall A	View Abstract
TUES	329	David Trudil	New Horizons Diagnostics Corporation	679	Microphysiological Systems as Tools for Non-Invasive Diagnostics	Linear Peptide Micro Array Platform for Development of Mucosal Immune Enhancers and Saliva-Based Diagnostics	Hall A	View Abstract
WED	330	Daniel Angelini	U.S. Army DEVCOM Chemical Biological Center	208	Microphysiological Systems as Tools for Non-Invasive Diagnostics	Multiomic Comparison of Sulfur Mustard-exposed Human and Rat EpiAirway Tissues.	Hall A	View Abstract
TUES	331	Rebecca Blackwood	Darwin Biosciences, Boulder	609	Microphysiological Systems as Tools for Non-Invasive Diagnostics	Optimization of a point-of-need infectious disease diagnostic through human factors and usability testing	Hall A	View Abstract
WED	332	Conor Jenkins	U.S. Army DEVCOM Chemical Biological Center	229	Microphysiological Systems as Tools for Non-Invasive Diagnostics	Soldier-on-a-chip: Multi-omic investigation of Staphylococcal Entertoxin B exposures in Microphysiology systems	Hall A	View Abstract
TUES	333	Maria Arevalo	U.S. Army DEVCOM Chemical Biological Center	168	Microphysiological Systems as Tools for Non-Invasive Diagnostics	Towards the agnostic future of diagnostics: untargeted nanopore sequencing of biological fluids	Hall A	View Abstract
WED	334	April Kloxin	University of Delaware	543	Microphysiological Systems as Tools for Non-Invasive Diagnostics	Well-defined bioinspired multidimensional culture systems for studying cellular responses to injury and pathogens	Hall A	View Abstract
TUES	335	Sangram Redkar	Arizona State University	108	Minds in Sync: Exploring the Nexus of Humans on a Chip and Wearable Technologies on Cognitive Measures of Human Performance	Ear Wearable Device (EWD) for Measuring Core Body Temperature, EKG, SpO2 and Other Physiological Signatures.	Hall A	View Abstract
TUES	336	Sangram Redkar	Arizona State University	107	Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications	Hybrid AI/ML Approach to Determine Chemical Warfare Agent (CWA) Exposure using Ocular Biomarkers (OB).	Hall A	View Abstract
TUES	337	Laura Weinstock	Sandia National Laboratories	409	Minds in Sync: Exploring the Nexus of Humans on a Chip and Wearable Technologies on Cognitive Measures of Human Performance - Session Chairs: Sweta Batni and Chia-Wei Tsai	An Applied Risk Assessment Methodology for Identification, Prioritization, and Mitigation of Adverse Events from Emerging Neurotechnology	Hall A	View Abstract
TUES	338	Laura Weinstock	Sandia National Laboratories	373	Revolutionizing Biomedical Research: Integrating Cutting-edge AI/ML to Unleash Innovation in Drug Discovery and Therapeutics Development	Mixed CNN-Attention machine learning model for predicting gene regulatory relationships across fungal species towards developing computational methods for defending against emerging pathogenic fungi.	Hall A	View Abstract
TUES	339	Stephen Kirby	U.S. Army Medical Research Institute of Chemical Defense	537	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	A binding solution to a lethal problem, chemical defense wound bandage incorporating PTE-CBD	Hall A	View Abstract
WED	340	Sarah Katoski	U.S. Army DEVCOM Chemical Biological Center	177	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	A Design for Decon	Hall A	View Abstract
TUES	341	Steven Kennon	Valent Applications Ltd	295	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	Advanced Concepts in Automated Systems for Chemical Weapons Disposal in Remote Environments	Hall A	View Abstract
WED	342	Emma Biesiada	CU Boulder	417	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	Autonomous Surface and Airborne Chemical and Biological Decontamination Via Peroxide Enhanced Germicidal Irradiation (PEGI)	Hall A	View Abstract
TUES	343	Katrina McConkey	Environmental Protection Agency	191	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	Biological Incident Response: Building Knowledge Through Operational Testing and Exercises	Hall A	View Abstract
WED	344	Joseph Myers	U.S. Army DEVCOM Chemical Biological Center	162	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	Chemical Hot Air Decontamination of Complex Features and Realistic Items	Hall A	View Abstract
WED	345	Joseph Myers	U.S. Army DEVCOM Chemical Biological Center	164	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	Decontamination of Chemical Contaminants from Sub-zero to Hot temperatures	Hall A	View Abstract
WED	346	Sooyeon Cho	Sungkyunkwan University	114	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	Cold Atmospheric Plasma Based H2O2 Decontaminant Production and Its On-Site and Real-Time Diagnostic System	Hall A	View Abstract
TUES	347	Namjun KIM	Agency For Defense Development	283	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	Decomposition mechanism of Organophosphate-Based Nerve Agents in the Plasma-Treated Water Environment: Theoretical Study of Decomposition Reaction under Acidic Condition	Hall A	View Abstract
WED	348	Sangmoon Byun	Agency for Defense Development	282	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	Decontamination experiments on various contaminated coupons by chemical warfare agents	Hall A	View Abstract
TUES	349	Collette Jolliffe	Triton Systems, Inc.	569	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	Decontamination of Broad Spectrum Biological Threats using an Atmospheric Plasma System	Hall A	View Abstract
WED	350	Joe Rossin	Guild Associates, Inc.	123	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	Decontamination of Unbroken Skin	Hall A	View Abstract
TUES	351	Lim Ji Won	Agency for Defense Development	284	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	Development and Implications of a Prototype Explosive Detonation System for the Demilitarization of Chemical Weapons in ROK	Hall A	View Abstract
WED	352	eunmee goh	Agency for defense development	145	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	Development of Unmanned Operation Indoor Decontamination System	Hall A	View Abstract
TUES	353	Janlyn Eikenberg	U.S. Army DEVCOM Chemical Biological Center	180	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	Development of a Chemical Decontaminant for Critical Areas	Hall A	View Abstract
WED	354	Tony Buhr	Naval Surface Warfare Center - Dahlgren	647	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	Disinfection of Building, Facility, and Platform Interiors	Hall A	View Abstract
WED	355	Tony Buhr	Naval Surface Warfare Center - Dahlgren	640	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	CORONAVIRUSES (CV) AND Φ6 CORRELATION TESTING TO CHARACTERIZE ENVELOPED VIRUS PREPARATION, VIRUS DEBRIS, STABILIZATION AND DECONTAMINATION	Hall A	View Abstract
WED	356	Lawrence Dubois	Nanoionix, LLC	480	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	Durable, permanent self-decontaminating paints and coatings for defense applications	Hall A	View Abstract
TUES	357	Vladimir Savransky	Emergent BioSolutions Inc.	15	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	Efficacy of RSDL® (Reactive Skin Decontamination Lotion Kit) against Novichok Nerve Agents	Hall A	View Abstract
WED	358	Marilyn Lee	U.S. Army DEVCOM Chemical Biological Center	340	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	Encapsulation of cell-free bio-reactions: delivering DNA-programmable functions to materials	Hall A	View Abstract
TUES	359	Eyob Kebede	Arba Minch University	445	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	Green Synthesis of TiO2 Nanoparticles Using Maerua Oblongifolia Root Extract for Hazard Mitigation: A Preliminary Investigation	Hall A	View Abstract
WED	360	Brent Mantooth	U.S. Army DEVCOM Chemical Biological Center	291	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	Hazard mitigation - from science to systems	Hall A	View Abstract
TUES	361	Jani Hakala	VTT Technical Reseach Centre of Finland	144	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	Heatless Vaporization of Liquid Decontaminants	Hall A	View Abstract
WED	362	Brian Zutter	Sandia National Laboratories	359	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	High-Current-Density Microbial Fuel Cells for Wastewater Bioremediation	Hall A	View Abstract
TUES	363	Jeff Canning	Gamma Pulse	658	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	How KillViD, a pulse powered plasma solution achieves 100% biological air contaminate destruction: Bench testing and live environment testing results	Hall A	View Abstract
WED	364	Andres Sanchez	Sandia National Laboratories	483	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	Mitigating aerosolized threats with the Spray Knockdown system in a wide area urban transportation environment	Hall A	View Abstract
TUES	365	youngho Jin	Chung Ang University	439	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	MoS2/ UiO-66-NH2 nanocomposites for photocatalytic degradation of chemical warfare agents	Hall A	View Abstract
TUES	366	youngho Jin	Chung Ang University	440	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	CNF/UiO-66-NH2 aerogel nanocomposites for photocatalytic degradation of chemical warfare agents	Hall A	View Abstract
TUES	367	Chris Hollars	MRIGlobal	397	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	Next Generation Expeditionary Infrastructure: ATHENA	Hall A	View Abstract
WED	368	Kyeong Min Cho	Agency for Defense Development	457	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	On-site and on-demand Production of Decontaminant Using Plasma Feactor	Hall A	View Abstract
WED	369	Kyeong Min Cho	Agency for Defense Development	455	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	Development of Aerosol Decontamination Module for Autonomous Indoor Decontamination System	Hall A	View Abstract
WED	370	Chin Li Cheung	University of Nebraska-Lincoln	184	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	Plasma-assisted Destruction of Fenitrothion by a Falling-Film Plasma Reactor	Hall A	View Abstract
TUES	371	Hermes Huang	Smiths Detection	345	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	Proximate Chemical Agent Detector (PCAD) Testing at Desert Tempest 2024 for Vehicle Decontamination Assessment	Hall A	View Abstract
WED	372	Bruce Salter	ARCTOS Technology Solutions	79	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	Renewable Antimicrobial Paints for Interior Surfaces	Hall A	View Abstract
TUES	373	Zachary Canter	US Army Medical Research Institute of Chemical Defense	276	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	SkinKast: A multi-modal dermal disclosure spray for the rapid detection of chemical warfare agents on intact skin	Hall A	View Abstract
WED	374	Shawn Stevenson	U.S. Army DEVCOM Chemical Biological Center	200	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	The evaluation of contaminant emission and transfer from a “used” decontaminant	Hall A	View Abstract
TUES	375	Hunter Vibbert	JHU/APL	663	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	Threat Agnostic Fenton Decon	Hall A	View Abstract
WED	376	Eugene Demchuk	Agency for Toxic Substances and Disease Registry	360	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	Towards Accurate Determination of Short-Term Inhalation Chemical Exposure Thresholds: Test Cases of Phosgene and Tear Gas (CS)	Hall A	View Abstract
TUES	377	Shannon Serre	US Environmental Protection Agency	21	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	Urban Area Remediation following a Biological Agent Release - Analysis for Coastal Operational Resiliency (AnCOR) Wide Area Demonstration	Hall A	View Abstract
WED	378	Robert diTargiani	USAMRICD	597	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	Wound Decontamination Evaluation Pipeline (WDEP): Decontamination of wounds contaminated with chemical warfare agents	Hall A	View Abstract
TUES	379	David Morton	DHS S&T CSAC	586	Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications	: Chemical Forensics Decision Support via the Chemical Agents Reactions Database (CARD)	Hall A	View Abstract
WED	380	James Lee	NSWCIHD	234	Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications	Testing Methods for Interpreting or Explaining Artificial Intelligence	Hall A	View Abstract
WED	381	James Lee	NSWCIHD	235	Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications	Accurately Predicting Non-covalent Interactions	Hall A	View Abstract
WED	382	Samantha Erwin	Pacific Northwest National Laboratory	429	Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications	An AI-Driven Security Platform for Threat Awareness and Decision Support	Hall A	View Abstract
TUES	383	Stephen Houghton	SRC Inc.	500	Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications	Automated Property Prediction and Material File Generation for Hazard Prediction using PropCast	Hall A	View Abstract
WED	384	Stephen Davis	Battelle Memorial Institute	43	Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications	Chemical Fires Module (CFM) Updates – Battery Fire	Hall A	View Abstract
TUES	385	Christopher Dibble	Battelle Memorial Institute	541	Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications	Climate-based forecasting of dengue virus cases and vector habitat suitability in the United States	Hall A	View Abstract
WED	386	Catherine Fromen	University of Delaware	423	Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications	Development of an autonomous inhalation robot for chem/bio (AIR-CB) for real-world estimation of aerosolized threats	Hall A	View Abstract
TUES	387	Sian Jenkins	Riskaware Ltd	490	Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications	Enabling decision support with Next Generation disease forecasting and chemical hazard prediction.	Hall A	View Abstract
WED	388	Jennifer Corbin	Deloitte	641	Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications	Epidemiological Model Selection	Hall A	View Abstract
TUES	389	Michael Sohn	Lawrence Berkeley National Laboratory	697	Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications	Integrated Urban: Vision and Results for the Urban Hazard Assessment Capability	Hall A	View Abstract
TUES	390	Michael Sohn	Lawrence Berkeley National Laboratory	698	Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications	Propagating Uncertainty through Building Models	Hall A	View Abstract
TUES	391	Mario Citra	SRC Inc.	489	Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications	Strategies for Whole Body Combined Exposure - Focus on Nerve Agents for FXCODA	Hall A	View Abstract
WED	392	Paul Bieringer	Aeris, LLC	531	Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications	The Joint Outdoor-indoor Large Eddy Simulation (JOULES) for numerical weather prediction forecasting and analysis in urban environments	Hall A	View Abstract
TUES	393	Taylor Anderson	Naval Surface Warfare Center Indian Head Division	371	Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications	The US Navy Shipboard Performance Model	Hall A	View Abstract
WED	394	Kyle Niezgoda	Aeris, LLC	535	Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications	Transport and Dispersion Forecasting for Semi-Enclosed Venues: A Case Study at Stade de France using JOULES-NWP	Hall A	View Abstract
TUES	395	Paul Fenimore	Los Alamos National Laboratory	375	Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications	Uncertainty Quantification for Epidemiological Decision Support and Quantification of Mitigation Effectiveness	Hall A	View Abstract
TUES	397	Zheng Wang	US Naval Research Laboratory	648	Protection - Science and Technology Advances for Chemical and Biological Protection	2D Melanin Coatings for Chemical Warfare Agent Protection	Hall A	View Abstract
WED	398	Jeong-Yu Son	ADD	277	Protection - Science and Technology Advances for Chemical and Biological Protection	A decontamination study on a range of coupons contaminated by chemical warfare agents through an aerosol system	Hall A	View Abstract
TUES	399	Sang Myeon Lee	Agency for Defense Development	142	Protection - Science and Technology Advances for Chemical and Biological Protection	Alginate-based Composite Materials for Uses in Protection and Decontamination against Chemical Warfare Agents	Hall A	View Abstract
WED	400	Gary Piteo	US Army Chemical Biological Center BioTesting Division	615	Protection - Science and Technology Advances for Chemical and Biological Protection	Characterization of simulant and interferent aerosol fluorescence in the Active Standoff Chamber	Hall A	View Abstract
TUES	401	David McGarvey	U.S. Army Chemical Biological Center	339	Protection - Science and Technology Advances for Chemical and Biological Protection	Decontamination of Aircraft Interiors	Hall A	View Abstract
WED	402	William Creasy	U.S. Army Chemical Biological Center	253	Protection - Science and Technology Advances for Chemical and Biological Protection	Dependence of VX NMR Chemical Shifts on Mof (UIO-66-NH2) Solid	Hall A	View Abstract
TUES	403	James Montavon	Blueprint Biosecurity	587	Protection - Science and Technology Advances for Chemical and Biological Protection	Deploying far-UVC for biodefense: Opportunities and research priorities	Hall A	View Abstract
WED	404	Andrew Kuznicki	DTRA	218	Protection - Science and Technology Advances for Chemical and Biological Protection	Design of Zeolitic Imidazolate Frameworks Towards a More Efficient Sulfur Dioxide Adsorbent	Hall A	View Abstract
TUES	405	Gina Bang	Agency for Defense Development	281	Protection - Science and Technology Advances for Chemical and Biological Protection	Development and characterization of a Cu-Mg-Ce metal oxide composite for efficient degradation of DMMP	Hall A	View Abstract
WED	406	Trenton Tovar	U.S. Army DEVCOM Chemical Biological Center	165	Protection - Science and Technology Advances for Chemical and Biological Protection	Development of novel broad-spectrum sorbent to extend the lifetime of collective protection filters	Hall A	View Abstract
TUES	407	Matthew Evans	Draeger	442	Protection - Science and Technology Advances for Chemical and Biological Protection	Dräger’s VIPER filter technology, based on extruded monoliths, allows the offering of a new generation of respiratory protection technology with virtually zero breathing resistance, yet potentially still providing the required filtering performance against the threats a modern warfighter could encounter.	Hall A	View Abstract
WED	408	Martijn de Koning	TNO Defence, Safety & Security	477	Protection - Science and Technology Advances for Chemical and Biological Protection	Dual-Functional Mofs: Efficient Adsorption and Degradation of a Nerve Agent Simulant and a Pesticide for Protective Applications	Hall A	View Abstract
TUES	409	Seungjung Yu	Agency for Defense Development	156	Protection - Science and Technology Advances for Chemical and Biological Protection	Dynamic Swatch Test Method for Assessing Liquid Aerosol Penetration in Chemical Warfare Protective Clothing	Hall A	View Abstract
WED	410	Yongkyu An	Engineer Research and Development Center (ERDC) of the US Army Corps of Engineers	512	Protection - Science and Technology Advances for Chemical and Biological Protection	Effect of Envelope Tightening on Collective Biological Protection of Buildings	Hall A	View Abstract
TUES	411	Hui Wang	U.S. Army DEVCOM Chemical Biological Center	166	Protection - Science and Technology Advances for Chemical and Biological Protection	Elastomeric, omniphobic composites for protection applications	Hall A	View Abstract
WED	412	Philip Cox	Mainstream Engineering	470	Protection - Science and Technology Advances for Chemical and Biological Protection	Encapsulated Polymeric Structured Metal Organic Framework Beads for Adsorption and Reaction of Toxic Agents	Hall A	View Abstract
TUES	413	Behzad Rad	Lawrence Berkeley National Labs	685	Protection - Science and Technology Advances for Chemical and Biological Protection	Engineering Microbial Armor for Threat Detection	Hall A	View Abstract
WED	414	Kelly Basi	U.S. Army DEVCOM Chemical Biological Center	170	Protection - Science and Technology Advances for Chemical and Biological Protection	Establishment of a Biomanufacturing Pipeline to Support Alternative Manufacturing of Chem-Bio Defense Materials and to Secure Supply Chain Resiliency	Hall A	View Abstract
TUES	415	Bryan Ormond	North Carolina State University, Wilson College of Textiles	659	Protection - Science and Technology Advances for Chemical and Biological Protection	Evaluating the Impact of Dosing Vehicles and Occlusion States in Methyl Salicylate Absorption Through Porcine Skin: An In-Vitro Study	Hall A	View Abstract
WED	416	Nevine Amer	University of Hertfordshire	441	Protection - Science and Technology Advances for Chemical and Biological Protection	Exploring the Skin Decontamination Potential of a Novel Zirconium Hydroxide Prototype against Chemical Warfare Agents with Comparative Analysis to RSDL	Hall A	View Abstract
TUES	417	Mark Ginsberg	ERDC-CERL	528	Protection - Science and Technology Advances for Chemical and Biological Protection	Extended bioprotection of facilites	Hall A	View Abstract
WED	418	Greg Peterson	U.S. Army DEVCOM Chemical Biological Center	178	Protection - Science and Technology Advances for Chemical and Biological Protection	Fabrication of Novel Functional Composite Forms for Filtration	Hall A	View Abstract
TUES	419	Sergio Garibay	U.S. Army DEVCOM Chemical Biological Center	216	Protection - Science and Technology Advances for Chemical and Biological Protection	Formulation of chitosan-Mof-808 core-shell fibers for organophosphate hydrolysis under non-buffered conditions	Hall A	View Abstract
TUES	421	Jennifer Poole	Teledyne FLIR Defense	634	Protection - Science and Technology Advances for Chemical and Biological Protection	Integrated Soldier Protection System (ISPS): A Nanomanufactured Textile Composite Designed for in situ Chemical and Biological Agent Neutralization	Hall A	View Abstract
WED	422	Shelle McDonald	ARCTOS Technology Solutions	321	Protection - Science and Technology Advances for Chemical and Biological Protection	Investigating the Efficacy of Multiple Catalysts in Textiles for Protection against Vaporous Threats	Hall A	View Abstract
TUES	423	Katherine Ratliff	U.S. Environmental Protection Agency	331	Protection - Science and Technology Advances for Chemical and Biological Protection	Large-scale Bioaerosol Experiments to Support Enhanced Bioprotection of Facilities	Hall A	View Abstract
WED	424	Brady Hall	Luna Labs, LLC	154	Protection - Science and Technology Advances for Chemical and Biological Protection	Luna Labs' Next Generation, PFAS-free Class I CBRN Gloves	Hall A	View Abstract
TUES	425	Mohammad Khurram Javed	Virginia Tech	120	Protection - Science and Technology Advances for Chemical and Biological Protection	Macromorphological Control of Zr-based Metal-Organic Frameworks for Hydrolysis of a Nerve Agent Simulant	Hall A	View Abstract
WED	426	Anna Shneidman	Harvard University	747	Protection - Science and Technology Advances for Chemical and Biological Protection	Materials for energy storage for around-the-clock photocatalysis	Hall A	View Abstract
TUES	427	Benoit Maze	NCSU/NWI	30	Protection - Science and Technology Advances for Chemical and Biological Protection	Meltblown Coform for Chemical Protection Applications	Hall A	View Abstract
WED	428	Adam Hinkle	DCS Corporation, DEVCOM Chemical Biological Command	227	Protection - Science and Technology Advances for Chemical and Biological Protection	Molecular Simulation of the Activation of Metal Organic Frameworks	Hall A	View Abstract
TUES	429	James Whitten	Chemistry, University of Massachusetts Lowell	293	Protection - Science and Technology Advances for Chemical and Biological Protection	Multifunctional electrospun membranes on nylon-cotton fabrics for warfighter chemical protection	Hall A	View Abstract
WED	430	Ching Hsien Ho	University of Massachusetts Amherst	669	Protection - Science and Technology Advances for Chemical and Biological Protection	Nanocellulose ionogels for CWA protection	Hall A	View Abstract
TUES	431	Kevin Ulmes	U.S. Army DEVCOM Chemical Biological Center	386	Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications	RaDaRR: Unlocking Historical Data for Rapid Threat Assessment	Hall A	View Abstract
TUES	432	Kevin Ulmes	U.S. Army DEVCOM Chemical Biological Center	384	Protection - Science and Technology Advances for Chemical and Biological Protection	Nerve Agent ChE Operational Impact from Dermal Exposures	Hall A	View Abstract
TUES	433	Caspar Hoyer	University of Hertfordshire	452	Protection - Science and Technology Advances for Chemical and Biological Protection	Next Generation Technologies for Real-Time Evaluation of Protective Suits against Toxic Chemicals	Hall A	View Abstract
WED	434	Eric Prast	XCMR Inc.	564	Protection - Science and Technology Advances for Chemical and Biological Protection	Next-generation respiratory protective equipment for inactivation of airborne biological threats	Hall A	View Abstract
TUES	435	Katherine Simpson	ARCTOS Technology Solutions	358	Protection - Science and Technology Advances for Chemical and Biological Protection	PFAS-Free Omniphobic Surfaces via Micro- and Nano-Engineered Coatings	Hall A	View Abstract
WED	436	Henry Gibbons	UU.S. Army DEVCOM Chemical Biological Center	688	Protection - Science and Technology Advances for Chemical and Biological Protection	Rapid Biotechnology Prototyping Consortium	Hall A	View Abstract
TUES	437	Celine Tesvara	University of California, Los Angeles	425	Protection - Science and Technology Advances for Chemical and Biological Protection	Rapid Screening of Single Metal Atom Catalysts Supported on Titania for the Decomposition of Chemical Warfare Agent using Density Functional Theory	Hall A	View Abstract
WED	438	Brian France	TDA Research, Inc.	727	Protection - Science and Technology Advances for Chemical and Biological Protection	Reactive Materials for Personal Protective Equipment	Hall A	View Abstract
WED	439	Brian France	TDA Research, Inc.	157	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	Protecting Military Working Dogs in a Contaminated Environment	Hall A	View Abstract
WED	440	John Dresios	Leidos	607	Protection - Science and Technology Advances for Chemical and Biological Protection	Reconfigurable, Functionalized Fabric Platform for Broad Spectrum Chemical and Biological Protection	Hall A	View Abstract
WED	442	Arshia Sulaiman	Virginia Tech	78	Protection - Science and Technology Advances for Chemical and Biological Protection	Single Atoms Modification of Mof-808 for Nerve Agent and Simulant Degradation	Hall A	View Abstract
TUES	443	Francesco Fornasiero	Lawrence Livermore National Laboratory	182	Protection - Science and Technology Advances for Chemical and Biological Protection	Single-atom-catalyst Membranes for Chem/bio Protection	Hall A	View Abstract
TUES	445	Lauren Sherry	Guild Associates Inc	361	Protection - Science and Technology Advances for Chemical and Biological Protection	Point of Use Filter for Collective Protection Applications	Hall A	View Abstract
TUES	446	Lauren Sherry	Guild Associates Inc	362	Protection - Science and Technology Advances for Chemical and Biological Protection	Supplemental Filter for Enhanced TICs Removal	Hall A	View Abstract
TUES	447	Daniel Freedman	U.S. Army DEVCOM Soldier Center	90	Protection - Science and Technology Advances for Chemical and Biological Protection	The influence of textile properties on chemical-biological protective garment design and thermal burden	Hall A	View Abstract
WED	448	Alex Balboa	US Army DEVCOM Chemical Biological Center	219	Protection - Science and Technology Advances for Chemical and Biological Protection	Theoretical study of chemical warfare agent and reaction byproduct molecular structure: Enabling FTIR analysis	Hall A	View Abstract
TUES	449	Jimmy Nguyen	North Carolina State University	370	Protection - Science and Technology Advances for Chemical and Biological Protection	Toxic organophosphonate captured and degraded using macroscopic, monolithic metal-organic framework structures	Hall A	View Abstract
WED	450	Daniel Corbin	US Naval Research Laboratory	357	Protection - Science and Technology Advances for Chemical and Biological Protection	Tunable Adsorbents for Hazardous Chemicals by Post-Synthetic Modification of Zirconium Metal-Organic Frameworks	Hall A	View Abstract
TUES	451	Anne Walker	U.S. Army DEVCOM Chemical Biological Center	503	Protection - Science and Technology Advances for Chemical and Biological Protection	Utilizing advanced manufacturing technologies to enhance legacy production techniques for next generation personal protective equipment	Hall A	View Abstract
WED	452	Sisay Uota	Morgan State University	430	Quantum Technologies, Metamaterials, and the Future of CB Sensing	A simple benzothiazole-based sensor for cyanide detection: applications in environmental analysis and bio-imaging	Hall A	View Abstract
TUES	453	Phillip Wilcox	U.S. Army DEVCOM Chemical Biological Center	171	Quantum Technologies, Metamaterials, and the Future of CB Sensing	Assessment of Surface and Ground hAzards by Real-time Detection (ASGARD) – Proximate Chemical Agent Detector (PCAD)	Hall A	View Abstract
WED	454	Patricia McDaniel	U.S. Army DEVCOM Chemical Biological Center	765	Quantum Technologies, Metamaterials, and the Future of CB Sensing	Deployable Integrated Microsensor Evaluation System (DIMES)	Hall A	View Abstract
TUES	455	Jennifer Mobberley	Pacific Northwest National Laboratory	542	Quantum Technologies, Metamaterials, and the Future of CB Sensing	Detection of Enzymatic Activity using Commercial-off-the-Shelf (COTS) Nanopore Sequencing-based Instrument	Hall A	View Abstract
WED	456	Eric Languirand	U.S. Army DEVCOM Chemical Biological Center	255	Quantum Technologies, Metamaterials, and the Future of CB Sensing	Emergent explosive threats for use with threat anomaly detection (ThreAD)	Hall A	View Abstract
WED	457	Eric Languirand	U.S. Army DEVCOM Chemical Biological Center	254	Mitigation - Science and Technology Advances for Chemical and Biological Hazard Mitigation	Novel radial jet reattachment for analyte extraction from porous surfaces	Hall A	View Abstract
WED	458	Anthony Casale	US Army DEVCOM Chemical Biological Center	240	Quantum Technologies, Metamaterials, and the Future of CB Sensing	First-principles analysis of transition metal nitrates in oxide host sensor materials	Hall A	View Abstract
TUES	459	Joseph Palomba	U.S. Army DEVCOM Soldier Center	290	Quantum Technologies, Metamaterials, and the Future of CB Sensing	Hydrogel Technology for Emerging Colorimetrics (HyTEC): Metamaterials and Peptide Recognition Elements Combined for Eye-Readable Sensors	Hall A	View Abstract
WED	460	Benjamin McDowell	Leidos	709	Quantum Technologies, Metamaterials, and the Future of CB Sensing	Improving SWaP in THz detection using a laser-cooled Rydberg atomic sensor on a photonic integrated circuit	Hall A	View Abstract
TUES	461	Richard Kingsborough	MIT Lincoln Laboratory	70	Quantum Technologies, Metamaterials, and the Future of CB Sensing	Low-SWaP-C Colorimetric Detection of Vapor-Phase Chemical Threats	Hall A	View Abstract
WED	462	Richard Osgood	U.S. Army DEVCOM Soldier Center	632	Quantum Technologies, Metamaterials, and the Future of CB Sensing	Photonic crystal fiber optic sensing of molecules with a quantum rectifying infrared metasurface	Hall A	View Abstract
TUES	463	Pelagia Gouma	The Ohio State University	346	Quantum Technologies, Metamaterials, and the Future of CB Sensing	Respiratory Infection Single Exhale (RISE) Breath Test	Hall A	View Abstract
WED	464	Tyler Romig	University of Maryland	681	Quantum Technologies, Metamaterials, and the Future of CB Sensing	Tuning Multiferroic van der Waals materials for SWaP Microsensor Applications	Hall A	View Abstract
TUES	465	Ashok Ajoy	Lawrence Berkeley National Lab/ U.C. Berkeley	716	Quantum Technologies, Metamaterials, and the Future of CB Sensing	Ultrasensitive, High Sensitivity, High-Throughput, Quantum Sensing of CB Agents	Hall A	View Abstract
WED	466	Erik Emmons	U.S. Army DEVCOM Chemical Biological Center	372	Quantum Technologies, Metamaterials, and the Future of CB Sensing	Waveguide-Enhanced Raman Spectroscopy for Field Detection of Threat Vapors	Hall A	View Abstract
TUES	467	Jude Kelley	MIT Lincoln Laboratory	230	Quantum Technologies, Metamaterials, and the Future of CB Sensing	xPCR: An Ultra-Rapid and Portable Sensor for Automated Biothreat Surveillance	Hall A	View Abstract
WED	468	Justin Weins	Defense Threat Reduction Agency, Technical Reachback	297	Reaerosolization of Hazardous Materials: What Goes Down, Can Go Back Up Again	A Resistance Chemical Vapor Deposition Model Extended to TICs, TIMs, and CWAs: Model Sensitivity Insights	Hall A	View Abstract
TUES	469	Riley Newcastle	DTRA	315	Reaerosolization of Hazardous Materials: What Goes Down, Can Go Back Up Again	Deposition of powders on surfaces – and the implications for removal	Hall A	View Abstract
WED	470	Matthew Magnuson	US Environmental Protection Agency/office of Research and Development/Center for Environmental Solutions and Emergency Response	492	Reaerosolization of Hazardous Materials: What Goes Down, Can Go Back Up Again	Tactics and methods for prevention of resuspension of CBR contaminated particles	Hall A	View Abstract
TUES	471	Hyunsook Jung	Agency for Defense Development	140	Reaerosolization of Hazardous Materials: What Goes Down, Can Go Back Up Again	Velocity visualization flow field of liquid aerosols approaching the swatch test fabric	Hall A	View Abstract
TUES	472	Hyunsook Jung	Agency for Defense Development	141	Next Generation CB Hazard Prediction and Consequence Assessment with Multi-echelon Decision Support Applications	Chemical agent contamination analysis in the field operation-environment simulation using a 50-cm wind tunnel and hazard prediction model engine	Hall A	View Abstract
TUES	473	Nicholas Paparoidamis	USAMRICD	275	Revolutionizing Biomedical Research: Integrating Cutting-edge AI/ML to Unleash Innovation in Drug Discovery and Therapeutics Development	Application of Molecular Docking and Pharmacophore Methods to Identify Potential Reactivators of Nerve Agent-Inhibited Acetylcholinesterase	Hall A	View Abstract
WED	474	Kylene Kehn-Hall	Virginia Polytechnic Institute and State University	414	Revolutionizing Biomedical Research: Integrating Cutting-edge AI/ML to Unleash Innovation in Drug Discovery and Therapeutics Development	Comparative analysis of equine encephalitis viruses (EEVs), traumatic brain injuries (TBI), and organophosphorus nerve agents (OPNA) as a path to neuroprotective therapeutics	Hall A	View Abstract
TUES	475	Hau Nguyen	Los Alamos National Laboratory	630	Revolutionizing Biomedical Research: Integrating Cutting-edge AI/ML to Unleash Innovation in Drug Discovery and Therapeutics Development	Conotoxin Prediction and Classification: New Features to Increase Prediction Accuracy	Hall A	View Abstract
WED	476	Vivian Lin	Pacific Northwest National Laboratory	91	Revolutionizing Biomedical Research: Integrating Cutting-edge AI/ML to Unleash Innovation in Drug Discovery and Therapeutics Development	Discovery of non-canonical protein targets of fentanyl across tissues from animal models and humans using photoaffinity fentanyl probes	Hall A	View Abstract
TUES	477	Victor Ogungbe	The University of Alabama in Huntsville and Biomolecular Science LLC	286	Revolutionizing Biomedical Research: Integrating Cutting-edge AI/ML to Unleash Innovation in Drug Discovery and Therapeutics Development	Early-Stage Investigation of Small Molecule Inhibitors Targeting Eastern Equine Encephalitis Virus (EEEV) and Western Equine Encephalitis Virus (WEEV) non-structural protein 2 (nsP2) Protease.	Hall A	View Abstract
WED	478	Sayak Mukherjee	Battelle	563	Revolutionizing Biomedical Research: Integrating Cutting-edge AI/ML to Unleash Innovation in Drug Discovery and Therapeutics Development	In Silico Discovery and Optimization Tool for Peptide Discovery for Traumatic Brain Injury Therapeutics	Hall A	View Abstract
TUES	479	Liduo YIn	Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University	202	Revolutionizing Biomedical Research: Integrating Cutting-edge AI/ML to Unleash Innovation in Drug Discovery and Therapeutics Development	Machine Learning Identifies Genes Linked to Neurological Disorders Induced by Equine Encephalitis viruses (EEV), Traumatic Brain Injuries (TBI), and Organophosphorus nerve agents (OPNA)	Hall A	View Abstract
WED	480	George Drusano	University of Florida	536	Revolutionizing Biomedical Research: Integrating Cutting-edge AI/ML to Unleash Innovation in Drug Discovery and Therapeutics Development	Mathematical modeling and in vitro and invivo challenge models to identify optimal doses af drugs alone and in combination to cure the warfighter quickly and suppress resistance emergence	Hall A	View Abstract
TUES	481	Jerome Anthony Alvarez	US Naval Research Laboratory	41	Revolutionizing Biomedical Research: Integrating Cutting-edge AI/ML to Unleash Innovation in Drug Discovery and Therapeutics Development	Nanobody Thermostability Prediction using Structural and Sequence Features	Hall A	View Abstract
WED	482	Phillip Davis	MRIGlobal	677	Revolutionizing Biomedical Research: Integrating Cutting-edge AI/ML to Unleash Innovation in Drug Discovery and Therapeutics Development	Predictive genotype-to-phenotype modeling and applications in antivirals	Hall A	View Abstract
TUES	483	Johannes Schöneberg	University of California, San Diego	748	Revolutionizing Biomedical Research: Integrating Cutting-edge AI/ML to Unleash Innovation in Drug Discovery and Therapeutics Development	Self-supervised deep learning uncovers the semantic landscape of latent mitochondrial phenotypes in human organoids to reshape the future of drug development and diagnostics	Hall A	View Abstract
WED	484	Nathaniel Stemmler	SRC Inc.	494	Revolutionizing Biomedical Research: Integrating Cutting-edge AI/ML to Unleash Innovation in Drug Discovery and Therapeutics Development	Toxicity Read-Across Tools in CLEARR for Assessment of Emerging Threat Chemicals	Hall A	View Abstract
TUES	485	Allen Duplantier	Latham BioPharm Group	128	The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats	A structure-based drug design approach towards the discovery and lead optimization of inhibitors of alphavirus nsP2 helicase	Hall A	View Abstract
WED	486	Andy Eller	Teledyne FLIR Defense	708	The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats	Accelerating biological research using automated high-throughput two-dimensional tandem mass spectrometry	Hall A	View Abstract
TUES	487	Methun Kamruzzaman	Sandia National Labs	737	The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats	Accelerating Drug Discovery and Repurposing with MIRA: A Machine Learning and GenAI Approach	Hall A	View Abstract
WED	488	Corie Ralston	LBNL	382	The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats	An integrated structural biology platform for rapid discovery and development of diagnostics and therapeutics	Hall A	View Abstract
WED	489	Corie Ralston	Lawrence Berkeley National Lab	487	Threat Agent Defeat Modeling and Testing using WMD Simulants	A plug & play platform for peptoid-nanoparticle conjugates tuned for chemical and biological warfare agent detection and mitigation	Hall A	View Abstract
WED	490	Barney Bishop	George Mason University	721	The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats	Bioprospecting and application of prediction algorithms for the identification of novel amphibian antimicrobial and antiviral peptides	Hall A	View Abstract
TUES	491	James J. Collins	MIT	271	The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats	Deep learning-guided discovery and structural validation of marine toxin inhibitors	Hall A	View Abstract
WED	492	Stephen Hummel	U.S. Army - West Point	73	The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats	Development of a ML / AI Model for Oligonucleotide Design for Respiratory Viruses	Hall A	View Abstract
TUES	493	Pei Zhou	Duke University	48	The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats	Development of a Potent LpxC Inhibitor from Structural Insights and Machine Learning Analysis for Post-Exposure Prophylaxis Treatment of Antibiotic-Resistant Burkholderia pseudomallei in a Murine Infection Model	Hall A	View Abstract
WED	494	Mariavictoria Moreno	Southwest Research Institute	651	The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats	Discovery and development of filovirus inhibitors: Managing off-target risk of sodium channel block with pharmacophore modeling	Hall A	View Abstract
TUES	495	Bradley Kearney	National Defense Medical College / US Army Japan ESEP	88	The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats	Discovery of novel small-molecule compounds targeting the immune homeostasis protein TIPE2 using machine learning and high performance computing	Hall A	View Abstract
WED	496	Tamir Gonen	UCLA	16	The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats	Disruptive Technology to Design Broad-Spectrum Countermeasures and Vaccines	Hall A	View Abstract
TUES	497	Laura Dunphy	JHU/APL	653	The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats	Fung-AI: AI/ML-driven antifungal discovery	Hall A	View Abstract
WED	498	Szczepan Baran	VeriSIM Life, Inc	413	The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats	Implementing AI-driven approaches for development of the target-specific compounds with high affinity as an effective countermeasure against chemical threats	Hall A	View Abstract
TUES	499	Janice Chambers	Mississippi State University	305	The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats	In silico identification of potential oxime antidotes to organophosphate poisoning based on a platform of novel therapeutic substituted phenoxyalkyl pyridinium oximes	Hall A	View Abstract
WED	500	Mohammad Kiani	Temple University	74	The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats	In Silico Modeling to Repurpose FDA-Approved Drugs for Treating Sepsis	Hall A	View Abstract
TUES	501	James Omichinski	Université de Montréal	406	The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats	Leveraging AI and experimental approaches to identify Short Linear interacting Motifs (SLiMs) for antiviral therapeutics	Hall A	View Abstract
WED	502	Le Thanh Mai Pham	Sandia National Laboratories	135	The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats	Machine learning guided prediction of receptor binding and immune escape for SARS-COV-2	Hall A	View Abstract
TUES	503	Noah Winters	Battelle	57	The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats	Machine learning models to identify egg-adaptive mutations for rapid vaccine virus development	Hall A	View Abstract
WED	504	Hector Garcia Martin	Lawrence Berkeley National Lab	319	The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats	Next generation synthesis of therapeutic drugs through computational design and embedded experimental validation	Hall A	View Abstract
TUES	505	Colby Ford	Center for Computational Intelligence to Predict Health and Environmental Risks; The University of North Carolina at Charlotte	104	The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats	Rapid and flexible development of medical countermeasures with computational structural biology and artificial intelligence	Hall A	View Abstract
WED	506	Justin Reese	Lawrence Berkeley National Laboratory	686	The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats	RNA-targeted AI/ML Drug Repurposing Pipeline for Aerospace Medicine	Hall A	View Abstract
TUES	507	Steven Bradfute	University of New Mexico Health Sciences Center	623	The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats	Semi-Automated antiviral discovery with machine learning	Hall A	View Abstract
WED	508	Richelle Ntumy	United States Military Academy	746	The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats	Tailoring Oligonucleotide Lengths: Optimizing the Binding Specificity and Affinity for Target Respiratory Viruses	Hall A	View Abstract
TUES	509	Shailesh Date	Laboratory for Research in Complex Systems	702	The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats	Using AI-driven chemical biology tools for ultra-fast, ultra-high-throughput small molecule development to counter biological threats	Hall A	View Abstract
WED	510	Helen Yu	MachinaMinds	367	The Use of AI and Advanced Computer Systems to Develop Drugs Against New Emerging Threats	Utilizing geometric deep learning to enhance the accuracy of preclinical identification of drug candidates	Hall A	View Abstract
TUES	511	Kevin Hommema	Battelle	50	Threat Agent Defeat Modeling and Testing using WMD Simulants	A singular test capability for the measurement of environmental persistence of biological threats and simulants in aerosol and on surfaces	Hall A	View Abstract
TUES	512	Kevin Hommema	Battelle	720	Threat Agent Defeat Modeling and Testing using WMD Simulants	Flexible and Complementary Operationally Realistic Biodefense Testing	Hall A	View Abstract
TUES	513	Brenton Packer	Chemical Biological Center, Biotesting Division	604	Threat Agent Defeat Modeling and Testing using WMD Simulants	Aerosol generation and aerosol particle correlations on trials conducted with Sono-Tek Ultrasonic Nozzle in Joint Ambient Breeze Tunnel	Hall A	View Abstract
WED	514	Vasanthi Sivaprakasam	Naval Research Laboratory	514	Threat Agent Defeat Modeling and Testing using WMD Simulants	Ambient Air Test Facility for testing of Chemical Aerosol Identification Point Detection Sensors	Hall A	View Abstract
TUES	515	Brad Heater	Battelle Memorial Institute	150	Threat Agent Defeat Modeling and Testing using WMD Simulants	CRISPR-Cas9-mediated barcode insertion into Bacillus thuringiensis for surrogate tracking	Hall A	View Abstract
WED	516	Kenneth Manning	Naval Surface Warfare Center Indian Head	292	Threat Agent Defeat Modeling and Testing using WMD Simulants	Development of a System to Comprehensively Characterize Gas Forming Reaction Threats	Hall A	View Abstract
TUES	517	Wednesday Smith	USAMRICD	356	Threat Agent Defeat Modeling and Testing using WMD Simulants	Development of Assays for Novel Reactivators of Organophosphorus-Inhibited Human Acetylcholinesterase	Hall A	View Abstract
WED	518	John Cort	Pacific Northwest National Laboratory	238	Threat Agent Defeat Modeling and Testing using WMD Simulants	Identification and validation of protein-chemical threat interactions from activity-based protein profiling (ABPP) data	Hall A	View Abstract
TUES	519	Sun McMasters	DHS S&T CSAC	127	Threat Agent Defeat Modeling and Testing using WMD Simulants	Jack Rabbit III: Environmental Factors Affecting Ammonia Airborne Plume Transport & Dispersion	Hall A	View Abstract
WED	520	Carl Fossum	Virginia Tech	682	Threat Agent Defeat Modeling and Testing using WMD Simulants	Mechanistic diversity and the role of water in the hydrolysis of sarin by single transition metal atoms on Mof-808	Hall A	View Abstract
TUES	521	Leena A. Nylander-French	University of North Carolina, Gillings School of Global Public Health	620	Threat Agent Defeat Modeling and Testing using WMD Simulants	Model Predictions of MeS Skin Exposure Informed by the Variability of Metabolite Urinary Excretion in Controlled Human Exposures	Hall A	View Abstract
TUES	522	Leena A. Nylander-French	University of North Carolina, Gillings School of Global Public Health	622	Threat Agent Defeat Modeling and Testing using WMD Simulants	Development of a skin dosing method using Methyl Salicylate	Hall A	View Abstract
WED	524	Bryan Tienes	NSWC Indian Head Division	159	Threat Agent Defeat Modeling and Testing using WMD Simulants	Naval Surface Warfare Center Indian Head Division support to outdoor chemical simulant and biological surrogate releases in littoral and maritime environments.	Hall A	View Abstract
TUES	525	Robert F Williams	Los Alamos National Laboratory	738	Threat Agent Defeat Modeling and Testing using WMD Simulants	Nuclear Magnetic Resonance at Low Magnetic Fields for Signature Detection of Chemical Warfare Agents (CWAs) and Emerging Threats	Hall A	View Abstract
WED	526	Inge Corbin	DTRA JSTO	689	Threat Agent Defeat Modeling and Testing using WMD Simulants	Physical property review and assessment of diisopropyl methylphosphonate (DIMP)	Hall A	View Abstract
TUES	527	Francis Damico	US Army, DEVCOM Chemical Biological Center	595	Threat Agent Defeat Modeling and Testing using WMD Simulants	Portable Testbed for Bioaerosol Detector Performance Evaluation	Hall A	View Abstract
WED	528	Cris Lewis	Southwest Research Institute	712	Threat Agent Defeat Modeling and Testing using WMD Simulants	Simulant Chamber Testing	Hall A	View Abstract
TUES	529	Hergen Eilers	Washington State University	49	Threat Agent Defeat Modeling and Testing using WMD Simulants	Single-shot standoff hyperspectral Raman imaging of diisopropyl methylphosphonate	Hall A	View Abstract
TUES	530	Hergen Eilers	Washington State University	266	Threat Agent Defeat Modeling and Testing using WMD Simulants	An Overview of Research withing the Materials Science in Extreme Environments University Research Alliance	Hall A	View Abstract
TUES	531	Rebecca Weed	North Carolina State University	249	Threat Agent Defeat Modeling and Testing using WMD Simulants	Stable Isotope Tracer Method to Monitor Methyl Salicylate in Biological Matrices for Assessing Mustard Gas Exposure during Protective Clothing Testing	Hall A	View Abstract
WED	532	Steve Hanna	HANNA CONSULTANTS	124	Threat Agent Defeat Modeling and Testing using WMD Simulants	Steps after Jack Rabbit II Chlorine Field Experiment to Calibrate and Post-Process Concentration and Meteorological Observations Provided by DPG	Hall A	View Abstract
TUES	533	Tom Spicer	University of Arkansas	93	Threat Agent Defeat Modeling and Testing using WMD Simulants	Two-dimensional Particle Image Velocimetry measurements in a wind tunnel model of the Jack Rabbit II chlorine field tests	Hall A	View Abstract
WED	534	Cynthia Van Acker	USAMRICD	343	Threat Agent Defeat Modeling and Testing using WMD Simulants - Session Chair: Bruce Hinds	Developing an Assay to Further Elucidate the Interactions of Chemical Warfare Agents and Reactivators with Acetylcholinesterase	Hall A	View Abstract
TUES	535	Emily Luteran	Los Alamos National Laboratory	212	Toxin Medical Countermeasures - Development of Novel, Broad-Spectrum Countermeasures for Toxin Exposure	A method for simultaneous evaluation of blood brain barrier transport and therapeutic functionality in vitro	Hall A	View Abstract
WED	536	Julian Chen	Los Alamos National Laboratory	691	Toxin Medical Countermeasures - Development of Novel, Broad-Spectrum Countermeasures for Toxin Exposure	Aging of acetylcholinesterase, the movie: Understanding the mechanisms of dealkylation of organophosphorus-acetylcholinesterase adducts as a means of developing new medical countermeasures	Hall A	View Abstract
WED	538	Paul Peterson	Los Alamos National Laboratory	509	Toxin Medical Countermeasures - Development of Novel, Broad-Spectrum Countermeasures for Toxin Exposure	Development and Implementation of Biomimetic Shuttles that Transport Charged Oximes Across the Blood Brain Barrier While Maintaining Their Therapeutic Potential	Hall A	View Abstract
TUES	539	Masahiro Nakashima	National Defense Medical College	194	Toxin Medical Countermeasures - Development of Novel, Broad-Spectrum Countermeasures for Toxin Exposure	Development of a humanized mouse model to evaluate medical countermeasures of Staphylococcus aureus enterotoxin B	Hall A	View Abstract
WED	540	Zoe Vaugh	Oak Ridge Institute for Science and Education	302	Toxin Medical Countermeasures - Development of Novel, Broad-Spectrum Countermeasures for Toxin Exposure	Development of a Structure-Activity Relationship of Non-Oxime Based Reactivators for Nerve Agent-Inhibited Acetylcholinesterase	Hall A	View Abstract
TUES	541	Elizabeth Hamelin	CDC	633	Toxin Medical Countermeasures - Development of Novel, Broad-Spectrum Countermeasures for Toxin Exposure	Development of functional assays to confirm biological activity of select conotoxins	Hall A	View Abstract
WED	542	Nicola Wade	University of Glasgow	387	Toxin Medical Countermeasures - Development of Novel, Broad-Spectrum Countermeasures for Toxin Exposure	Discovery of medical countermeasures against α-conotoxins using a mRNA cyclic peptide display platform	Hall A	View Abstract
TUES	543	Michael Capper	University of Glasgow	106	Toxin Medical Countermeasures - Development of Novel, Broad-Spectrum Countermeasures for Toxin Exposure	Elucidating the precise mechanism of ⍺-Conotoxin antagonism at the muscle-type nicotinic acetylcholine receptor	Hall A	View Abstract
WED	544	Min Hoon LEE	ABION Inc., Seoul 08394, Republic of Korea / Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University	289	Toxin Medical Countermeasures - Development of Novel, Broad-Spectrum Countermeasures for Toxin Exposure	Evaluation of staphylococcal enterotoxin B subunit vaccine; assessment of vaccine efficacy and residual toxicity	Hall A	View Abstract
TUES	545	Larry Zana MS	Consegna Pharma Inc.	672	Toxin Medical Countermeasures - Development of Novel, Broad-Spectrum Countermeasures for Toxin Exposure	Evaluation of the Ability to Prevent Renarcotization After Carfentanil Challenge in Canines	Hall A	View Abstract
WED	546	Steven Turner	University of Southampton	313	Toxin Medical Countermeasures - Development of Novel, Broad-Spectrum Countermeasures for Toxin Exposure	Investigating a possible disulfide shuffling mechanism of alpha-conotoxins using QM/MM molecular dynamics simulation.	Hall A	View Abstract
TUES	547	Elizabeth Clarke	Los Alamos National Laboratory	364	Toxin Medical Countermeasures - Development of Novel, Broad-Spectrum Countermeasures for Toxin Exposure	Optimization of production and purification of nicotinic acetylcholine receptors (nAChRs) for toxin-binding analysis	Hall A	View Abstract
WED	548	Melody Zacharko	U.S. Army DEVCOM Chemical Biological Center	206	Toxin Medical Countermeasures - Development of Novel, Broad-Spectrum Countermeasures for Toxin Exposure	Testing and Evaluation of Synthesized Peptide Proteins using Quality Metrics	Hall A	View Abstract

December 2-5, 2024 | Fort Lauderdale, Florida

December 2-5, 2024 | Fort Lauderdale, Florida

Poster Listing

View Poster Session Floorplans